<!DOCTYPE html>
<html lang="en" dir="ltr" 
  xmlns="http://www.w3.org/1999/xhtml"
  xmlns:mml="http://www.w3.org/1998/Math/MathML">
  <head prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book#" >
    <!--[if IE]><![endif]-->
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<link rel="dns-prefetch" href="//stats.g.doubleclick.net" />
<link rel="dns-prefetch" href="//www.google-analytics.com" />
<link rel="dns-prefetch" href="//scholar.google.com" />
<link rel="dns-prefetch" href="//d33xdlntwy0kbs.cloudfront.net" />
<link rel="shortcut icon" href="https://www.biorxiv.org/sites/default/files/images/favicon.ico" type="image/vnd.microsoft.icon" />
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=3, minimum-scale=1, user-scalable=yes" />
<meta name="type" content="article" />
<meta name="category" content="article" />
<meta name="HW.identifier" content="/biorxiv/early/2019/04/12/606715.atom" />
<meta name="HW.pisa" content="biorxiv;606715v1" />
<meta name="DC.Format" content="text/html" />
<meta name="DC.Language" content="en" />
<meta name="DC.Title" content="More than efficacy revealed by single-cell analysis of antiviral therapeutics" />
<meta name="DC.Identifier" content="10.1101/606715" />
<meta name="DC.Date" content="2019-04-12" />
<meta name="DC.Publisher" content="Cold Spring Harbor Laboratory" />
<meta name="DC.Rights" content="© 2019, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission." />
<meta name="DC.AccessRights" content="restricted" />
<meta name="DC.Description" content="Development of antiviral therapeutics emphasizes minimization of the effective dose and maximization of the toxic dose, first in cell culture and later in animal models. Long-term success of an antiviral therapeutic is determined not only by its efficacy but also by the duration of time required for drug-resistance to evolve. We have developed a microfluidic device comprised of ~6000 wells, with each well containing a microstructure to capture single cells. We have used this device to characterize enterovirus inhibitors with distinct mechanisms of action. In contrast to population methods, single-cell analysis reveals that each class of inhibitor interferes with the viral infection cycle in a manner that can be distinguished by principal component analysis. Single-cell analysis of antiviral candidates reveals not only efficacy but also properties of the members of the viral population most sensitive to the drug, the stage of the lifecycle most affected by the drug, and perhaps even if the drug targets an interaction of the virus with its host." />
<meta name="DC.Contributor" content="Wu Liu" />
<meta name="DC.Contributor" content="Mehmet U. Caglar" />
<meta name="DC.Contributor" content="Zhangming Mao" />
<meta name="DC.Contributor" content="Andrew Woodman" />
<meta name="DC.Contributor" content="Jamie J. Arnold" />
<meta name="DC.Contributor" content="Claus O. Wilke" />
<meta name="DC.Contributor" content="Craig E. Cameron" />
<meta name="article:published_time" content="2019-04-12" />
<meta name="article:section" content="New Results" />
<meta name="citation_title" content="More than efficacy revealed by single-cell analysis of antiviral therapeutics" />
<meta name="citation_abstract" lang="en" content="&lt;h3&gt;SUMMARY&lt;/h3&gt;
&lt;p&gt;Development of antiviral therapeutics emphasizes minimization of the effective dose and maximization of the toxic dose, first in cell culture and later in animal models. Long-term success of an antiviral therapeutic is determined not only by its efficacy but also by the duration of time required for drug-resistance to evolve. We have developed a microfluidic device comprised of ~6000 wells, with each well containing a microstructure to capture single cells. We have used this device to characterize enterovirus inhibitors with distinct mechanisms of action. In contrast to population methods, single-cell analysis reveals that each class of inhibitor interferes with the viral infection cycle in a manner that can be distinguished by principal component analysis. Single-cell analysis of antiviral candidates reveals not only efficacy but also properties of the members of the viral population most sensitive to the drug, the stage of the lifecycle most affected by the drug, and perhaps even if the drug targets an interaction of the virus with its host.&lt;/p&gt;" />
<meta name="citation_journal_title" content="bioRxiv" />
<meta name="citation_publisher" content="Cold Spring Harbor Laboratory" />
<meta name="citation_publication_date" content="2019/01/01" />
<meta name="citation_mjid" content="biorxiv;606715v1" />
<meta name="citation_id" content="606715v1" />
<meta name="citation_public_url" content="https://www.biorxiv.org/content/10.1101/606715v1" />
<meta name="citation_abstract_html_url" content="https://www.biorxiv.org/content/10.1101/606715v1.abstract" />
<meta name="citation_full_html_url" content="https://www.biorxiv.org/content/10.1101/606715v1.full" />
<meta name="citation_pdf_url" content="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715.full.pdf" />
<meta name="citation_doi" content="10.1101/606715" />
<meta name="citation_num_pages" content="30" />
<meta name="citation_article_type" content="Article" />
<meta name="citation_section" content="New Results" />
<meta name="citation_firstpage" content="606715" />
<meta name="citation_author" content="Wu Liu" />
<meta name="citation_author_institution" content="Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park" />
<meta name="citation_author_email" content="wul28@psu.edu" />
<meta name="citation_author_email" content="cec9@psu.edu" />
<meta name="citation_author" content="Mehmet U. Caglar" />
<meta name="citation_author_institution" content="Center for Computational Biology and Bioinformatics, Institute for Cellular and Molecular Biology, and Department of Integrative Biology, The University of Texas at Austin" />
<meta name="citation_author" content="Zhangming Mao" />
<meta name="citation_author_institution" content="Department of Engineering Science and Mechanics, The Pennsylvania State University, University Park" />
<meta name="citation_author" content="Andrew Woodman" />
<meta name="citation_author_institution" content="Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park" />
<meta name="citation_author" content="Jamie J. Arnold" />
<meta name="citation_author_institution" content="Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park" />
<meta name="citation_author" content="Claus O. Wilke" />
<meta name="citation_author_institution" content="Center for Computational Biology and Bioinformatics, Institute for Cellular and Molecular Biology, and Department of Integrative Biology, The University of Texas at Austin" />
<meta name="citation_author" content="Craig E. Cameron" />
<meta name="citation_author_institution" content="Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park" />
<meta name="citation_author_email" content="wul28@psu.edu" />
<meta name="citation_author_email" content="cec9@psu.edu" />
<meta name="citation_reference" content="Andino, R., and Domingo, E. (2015). Viral quasispecies. Virology 479, 46–51." />
<meta name="citation_reference" content="Antona, D., Kossorotoff, M., Schuffenecker, I., Mirand, A., Leruez-Ville, M., Bassi, C., Aubart, M., Moulin, F., Lévy-Bruhl, D., Henquell, C., et al. (2016). Severe paediatric conditions linked with EV-A71 and EV-D68, France, May to October 2016. Eurosurveillance 21, 11–14." />
<meta name="citation_reference" content="Baize, S., Pannetier, D., Oestereich, L., Rieger, T., Koivogui, L., Magassouba, N., Soropogui, B., Sow, M. S., Keïta, S., De Clerck, H., et al. (2014). Emergence of Zaire Ebola virus disease in Guinea. N. Engl. J. Med. 371, 1418–1425." />
<meta name="citation_reference" content="Binford, S. L., Maldonado, F., Brothers, M. A., Weady, P. T., Zalman, L. S., Meador, J. W., Matthews, D. A., and Patick, A. K. (2005). Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor. Antimicrob. Agents Chemother. 49, 619–626." />
<meta name="citation_reference" content="Burt, F. J., Rolph, M. S., Rulli, N. E., Mahalingam, S., and Heise, M. T. (2012) Chikungunya: a re-emerging virus. Lancet 379, 662–671." />
<meta name="citation_reference" content="Caglar, M. U., Teufel, A. I., and Wilke, C. O. (2018). Sicegar: R package for sigmoidal and double-sigmoidal curve fitting. PeerJ 6, e4251." />
<meta name="citation_reference" content="Campbell, G. L., Marfin, A. A., Lanciotti, R. S., and Gubler, D. J. (2002). West Nile virus. Lancet Infect. Dis. 2, 519–529." />
<meta name="citation_reference" content="Campos, G. S., Bandeira, A. C., and Sardi, S. I. (2015). Zika virus outbreak, Bahia, Brazil. Emerg. Infect. Dis. 21, 1885–1886." />
<meta name="citation_reference" content="Carroll, S. S., Tomassini, J. E., Bosserman, M., Getty, K., Stahlhut, M. W., Eldrup, A. B., Bhat, B., Hall, D., Simcoe, A. L., LaFemina, R., et al. (2003). Inhibition of hepatitis C virus RNA replication by 2’-modified nucleoside analogs. J. Biol. Chem. 278, 11979–11984." />
<meta name="citation_reference" content="Chatterjee, S., and Burns, T. F. (2017). Targeting heat shock proteins in cancer: a promising therapeutic approach. Int. J. Mol. Sci. 18, 1978." />
<meta name="citation_reference" content="Cihlar, T., and Ray, A. S. (2010). Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine. Antiviral Res. 85, 39–58." />
<meta name="citation_reference" content="Combe, M., Garijo, R., Geller, R., Cuevas, J. M., and Sanjuán, R. (2015).Single-cell analysis of RNA virus infection identifies multiple genetically diverse viral genomes within single infectious units. Cell Host Microbe 18, 424–432." />
<meta name="citation_reference" content="de Leuw, P., and Stephan, C. (2018). Protease inhibitor therapy for hepatitis C virus-infection. Expert Opin. Pharmacother. 19, 577–587." />
<meta name="citation_reference" content="De Palma, A. M., Pürstinger, G., Wimmer, E., Patick, A. K., Andries, K., Rombaut, B., De Clercq, E., and Neyts, J. (2008). Potential use of antiviral agents in polio eradication. Emerg. Infect. Dis. 14, 545–551." />
<meta name="citation_reference" content="Derrida, B. (1997). From random walks to spin glasses. Physica D 107, 186–198." />
<meta name="citation_reference" content="Dunning, J., Baillie, J. K., Cao, B., and Hayden, F. G. (2014). Antiviral combinations for severe influenza. Lancet Infect. Dis. 14, 1259–1270." />
<meta name="citation_reference" content="Eltahla, A. A., Luciani, F., White, P. A., Lloyd, A. R., and Bull, R. A. (2015). Inhibitors of the hepatitis C virus polymerase, mode of action and resistance. Viruses 7, 5206–5224." />
<meta name="citation_reference" content="Geller, R., Taguwa, S., and Frydman, J. (2012). Broad action of Hsp90 as a host chaperone required for viral replication. Biochim. Biophys. Acta 1823, 698–706." />
<meta name="citation_reference" content="Geller, R., Vignuzzi, M., Andino, R., and Frydman, J. (2007). Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Genes Dev. 21, 195–205." />
<meta name="citation_reference" content="Guo, F., Li, S., Caglar, M. U., Mao, Z., Liu, W., Woodman, A., Arnold, J. J., Wilke, C. O., Huang, T. J., and Cameron, C. E. (2017). Single-cell virology: on-chip investigation of viral infection dynamics. Cell Rep. 21, 1692–1704." />
<meta name="citation_reference" content="Heldt, F. S., Kupke, S. Y., Dorl, S., Reichl, U., and Frensing, T. (2015).Single-cell analysis and stochastic modelling unveil large cell-to-cell variability in influenza A virus infection. Nat. Commun. 6, 8938." />
<meta name="citation_reference" content="Hofmann, W. P., Soriano, V., and Zeuzem, S. (2009). Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection. In Antiviral Strategies. (Berlin, Heidelberg: Springer), pp. 321–346." />
<meta name="citation_reference" content="Hwang, M., Moretti, L., and Lu, B. (2009). HSP90 inhibitors: multi-targeted antitumor effects and novel combinatorial therapeutic approaches in cancer therapy. Curr. Med. Chem. 16, 3081–3092." />
<meta name="citation_reference" content="Jordheim, L. P., Durantel, D., Zoulim, F., and Dumontet, C. (2013). Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases. Nat. Rev. Drug Discov. 12, 447–464." />
<meta name="citation_reference" content="Peiris, J. S., Lai, S. T., Poon, L. L., Guan, Y., Yam, L. Y., Lim, W., Nicholls, J., Yee, W. K., Yan, W. W., Cheung, M. T., et al. (2003). Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361, 1319–1325." />
<meta name="citation_reference" content="Pokorna, J., Machala, L., Rezacova, P., and Konvalinka, J. (2009). Current and novel inhibitors of HIV protease. Viruses 1, 1209–1239." />
<meta name="citation_reference" content="Prince, T. L., Kijima, T., Tatokoro, M., Lee, S., Tsutsumi, S., Yim, K., Rivas, C., Alarcon, S., Schwartz, H., Khamit-Kush, K., et al. (2015). Client proteins and small molecule inhibitors display distinct binding preferences for constitutive and stress-induced HSP90 isoforms and their conformationally restricted mutants. PLoS One 10, e0141786." />
<meta name="citation_reference" content="Raj, A., and van Oudenaarden, A. (2008). Nature, nurture, or chance: stochastic gene expression and its consequences. 2008, 135, 216–226." />
<meta name="citation_reference" content="Roe, S. M., Prodromou, C., O’Brien, R., Ladbury, J. E., Piper, P. W., and Pearl, L. H. (1999). Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J. Med. Chem. 42, 260–266." />
<meta name="citation_reference" content="Russell, A. B., Trapnell, C., and Bloom, J. D. (2018). Extreme heterogeneity of influenza virus infection in single cells. Elife 7, e32303." />
<meta name="citation_reference" content="Sidera, K., and Patsavoudi, E. (2014). HSP90 inhibitors: current development and potential in cancer therapy. Recent Pat. Anticancer Drug Discov. 9, 1–20." />
<meta name="citation_reference" content="Sofia, M. J., Chang, W. S., Furman, P. A., Mosley, R. T., and Ross, B. S. (2012). Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA- polymerase. J. Med. Chem. 55, 2481–2531." />
<meta name="citation_reference" content="Stuyver, L. J., McBrayer, T. R., Tharnish, P. M., Clark, J., Hollecker, L., Lostia, S., Nachman, T., Grier, J., Bennett, M. A., Xie, M. Y., et al. (2006). Inhibition of hepatitis C replicon RNA synthesis by beta-D-2’-deoxy-2’-fluoro-2’-C-methylcytidine: a specific inhibitor of hepatitis C virus replication. Antivir. Chem. Chemother. 17, 79–87." />
<meta name="citation_reference" content="Wang, H. M., and Liang, P. H. (2010). Picornaviral 3C protease inhibitors and the dual 3C protease/coronaviral 3C-like protease inhibitors. Expert Opin. Ther. Pat. 20, 59–71." />
<meta name="citation_reference" content="Wang, Y., Jin, F., Wang, R., Li, F., Wu, Y., and Kitazato, K. (2017). HSP90: a promising broad-spectrum antiviral drug target. Arch. Virol. 162, 3269–3282." />
<meta name="citation_reference" content="Wiseman, S., and Domany, E. (1998). Finite-size scaling and lack of self-averaging in critical disordered systems. Phys. Rev. Lett. 81, 22–25." />
<meta name="citation_reference" content="Wlodawer, A., and Vondrasek, J. (1998). Inhibitors of HIV-1 protease: A major success of structure-assisted drug design. Annu. Rev. Biophys. Biomol. Struct. 27, 249–284." />
<meta name="citation_reference" content="Ying, W., Du, Z., Sun, L., Foley, K. P., Proia, D. A., Blackman, R. K., Zhou, D., Inoue, T., Tatsuta, N., Sang, J., et al. (2012). Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapy. Mol. Cancer Ther. 11, 475–484." />
<meta name="twitter:title" content="More than efficacy revealed by single-cell analysis of antiviral therapeutics" />
<meta name="twitter:site" content="@biorxivpreprint" />
<meta name="twitter:card" content="summary" />
<meta name="twitter:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png" />
<meta name="twitter:description" content="Development of antiviral therapeutics emphasizes minimization of the effective dose and maximization of the toxic dose, first in cell culture and later in animal models. Long-term success of an antiviral therapeutic is determined not only by its efficacy but also by the duration of time required for drug-resistance to evolve. We have developed a microfluidic device comprised of ~6000 wells, with each well containing a microstructure to capture single cells. We have used this device to characterize enterovirus inhibitors with distinct mechanisms of action. In contrast to population methods, single-cell analysis reveals that each class of inhibitor interferes with the viral infection cycle in a manner that can be distinguished by principal component analysis. Single-cell analysis of antiviral candidates reveals not only efficacy but also properties of the members of the viral population most sensitive to the drug, the stage of the lifecycle most affected by the drug, and perhaps even if the drug targets an interaction of the virus with its host." />
<meta name="og-title" property="og:title" content="More than efficacy revealed by single-cell analysis of antiviral therapeutics" />
<meta name="og-url" property="og:url" content="https://www.biorxiv.org/content/10.1101/606715v1" />
<meta name="og-site-name" property="og:site_name" content="bioRxiv" />
<meta name="og-description" property="og:description" content="Development of antiviral therapeutics emphasizes minimization of the effective dose and maximization of the toxic dose, first in cell culture and later in animal models. Long-term success of an antiviral therapeutic is determined not only by its efficacy but also by the duration of time required for drug-resistance to evolve. We have developed a microfluidic device comprised of ~6000 wells, with each well containing a microstructure to capture single cells. We have used this device to characterize enterovirus inhibitors with distinct mechanisms of action. In contrast to population methods, single-cell analysis reveals that each class of inhibitor interferes with the viral infection cycle in a manner that can be distinguished by principal component analysis. Single-cell analysis of antiviral candidates reveals not only efficacy but also properties of the members of the viral population most sensitive to the drug, the stage of the lifecycle most affected by the drug, and perhaps even if the drug targets an interaction of the virus with its host." />
<meta name="og-type" property="og:type" content="article" />
<meta name="og-image" property="og:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png" />
<meta name="citation_date" content="2019-04-12" />
<link rel="alternate" type="application/pdf" title="Full Text (PDF)" href="/content/10.1101/606715v1.full.pdf" />
<link rel="alternate" type="text/plain" title="Full Text (Plain)" href="/content/10.1101/606715v1.full.txt" />
<link rel="alternate" type="application/vnd.ms-powerpoint" title="Powerpoint" href="/content/10.1101/606715v1.ppt" />
<meta name="description" content="bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution" />
<meta name="generator" content="Drupal 7 (http://drupal.org)" />
<link rel="canonical" href="https://www.biorxiv.org/content/10.1101/606715v1" />
<link rel="shortlink" href="https://www.biorxiv.org/node/596459" />
    <title>More than efficacy revealed by single-cell analysis of antiviral therapeutics | bioRxiv</title>  
    <link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__jMRAK66KMC1e4TQlwUNn3KiWVDC5AjueUAYEm1xBY_U__KSUjdT4jdcJ4qJz6fKY1K9WkYh1a5EcaWZxt_-zbTis__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/all/modules/highwire/highwire/highwire.style.highwire.css?q8qadd" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__qlYh2rDEXmsOlJKnxoaEiN2PoZU7YzDXSSTk6K1VAQE__XkaAZGAgxyDmOmv0mrGL0sA-jzEgAbgA12amvVPlIf0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__GFpBMW7A95ZNl4oKhiI_0u7WD_8tFHiDfbKIVNkYgis__uourhtZYS_vAk2DtacwQIGmpE376HP4afgwMlmHZpq0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<style type="text/css" media="all">
/* <![CDATA[ */
#sliding-popup.sliding-popup-bottom,#sliding-popup.sliding-popup-bottom .eu-cookie-withdraw-banner,.eu-cookie-withdraw-tab{background:gray}#sliding-popup.sliding-popup-bottom.eu-cookie-withdraw-wrapper{background:transparent}#sliding-popup .popup-content #popup-text h1,#sliding-popup .popup-content #popup-text h2,#sliding-popup .popup-content #popup-text h3,#sliding-popup .popup-content #popup-text p,.eu-cookie-compliance-secondary-button,.eu-cookie-withdraw-tab{color:#fff !important}.eu-cookie-withdraw-tab{border-color:#fff}.eu-cookie-compliance-more-button{color:#fff !important}
/* ]]> */
</style>

<!--[if lte IE 7]>
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__ElJr3PIJEvw3qLXc1cnYiLj2G4KgDPSXFOfm6Phf8hw__JdWGm15cDWjsK6KrFlQVXQix9YgNeYysf22XZHj-Y-c__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<![endif]-->
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__B6tGdsQSt1vT8d8j-19-oS4FKJe83RrSNBkjPs9jfos__6VkE5WcQmmQpSVTQx-xS2-zn_nlwFlDm-EN1HLJNjrA__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__78WRxe8YsWkYp6RcQ_VwTjFG__x9mi_NTPqoxAwFUsA__F3sVKlGyHKCaAPI_WdiHD7l_-05B6b9bLdUwzi1me90__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />

<!--[if (lt IE 9)&(!IEMobile)]>
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__XH6bpcI0f2dImc-p674DLCZtWBGb-QwxJK1YexVGtno__vUceGprdo5nIhV6DH93X7fI3r8RcTJbChbas9TQXeW4__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<![endif]-->

<!--[if gte IE 9]><!-->
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__2WBMox6sOrN42ss5lCnH7WWVRdFdJCxtTKnQJYRwTE4__yqNvNYLvMpjy3ffuJrjjm9uW2i-Me1c23KLYuWHaqio__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<!--<![endif]-->
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__dAeSAHswzRXxn-2n4D6zNPmcZDmwaqqLzE-2ab_8jKw__f_9pwrTE8mmshoJRfurwkQ36QonD_Jiwbop2sscnkrE__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://d33xdlntwy0kbs.cloudfront.net/cshl_custom.css" media="all" />
    <script type="text/javascript">
<!--//--><![CDATA[//><!--
/*!
 * yepnope1.5.4
 * (c) WTFPL, GPLv2
 */
(function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i<a.length;i++)j=a[i],e(j)?g(j,0,l,0):w(j)?B(j):Object(j)===j&&h(j,l);else Object(a)===a&&h(a,l)},B.addPrefix=function(a,b){z[a]=b},B.addFilter=function(a){x.push(a)},B.errorTimeout=1e4,null==b.readyState&&b.addEventListener&&(b.readyState="loading",b.addEventListener("DOMContentLoaded",A=function(){b.removeEventListener("DOMContentLoaded",A,0),b.readyState="complete"},0)),a.yepnope=k(),a.yepnope.executeStack=h,a.yepnope.injectJs=function(a,c,d,e,i,j){var k=b.createElement("script"),l,o,e=e||B.errorTimeout;k.src=a;for(o in d)k.setAttribute(o,d[o]);c=j?h:c||f,k.onreadystatechange=k.onload=function(){!l&&g(k.readyState)&&(l=1,c(),k.onload=k.onreadystatechange=null)},m(function(){l||(l=1,c(1))},e),i?k.onload():n.parentNode.insertBefore(k,n)},a.yepnope.injectCss=function(a,c,d,e,g,i){var e=b.createElement("link"),j,c=i?h:c||f;e.href=a,e.rel="stylesheet",e.type="text/css";for(j in d)e.setAttribute(j,d[j]);g||(n.parentNode.insertBefore(e,n),m(c,0))}})(this,document);

//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/all/libraries/modernizr/modernizr.min.js?q8qadd"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
yepnope({
  test: Modernizr.matchmedia,
  nope: '/sites/all/libraries/media-match/media.match.min.js'
});
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__yOhrJUBmMpN-jsuQlJYmS8ovkQU6I6KInr295HrSTb0__c--zHhbuOWmkdWkJYXiNWDmkpDRPesmbBjGlQcyqBOY__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var _prum=[['id', '52e95df3abe53d2e33000000'], ['mark', 'firstbyte',
      (new Date()).getTime()]]; (function() {
      var s=document.getElementsByTagName('script')[0],
      p=document.createElement('script');
      p.async='async'; p.src='//rum-static.pingdom.net/prum.min.js';s.parentNode.insertBefore(p,s);})();
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js___KyvuEvfmewWxdOLBXTYsSUo8Pfm_DijV6fWtGvSL_k__HSKkTgIr7nDcdvQYewipf6v4ak6ZLUOQkwPj44wKouA__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript" async="async" src="https://scholar.google.com/scholar_js/casa.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__OGPr3wJNGw2BAY3Tj6TjIBwKmjQh5i-7muOaPrr0MFA__fCWiU_pDm6xztXUSccH7zrf5422-kgOkuLdWyafrH_0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript" src="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__hqoKSXYZqkcZkXP--ltzsy0Y3txW5TJBw6HT1khr30Y__6_HqNYoBVMxlkWZwdscqCLCtCxpOhl9_rIOpTDdaI0k__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
if(typeof window.MathJax === "undefined") window.MathJax = { menuSettings: { zoom: "Click" } };
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__lrItkPGmrIuH-E_sdUWEK2i9eTqLar16BAHVxNTWqrc__FhtnljBrjuzYWWrT_f4OYV4jtMBituhMpusb3h0m0rY__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
(function(i,s,o,g,r,a,m){i["GoogleAnalyticsObject"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,"script","//www.google-analytics.com/analytics.js","ga");ga("create", "UA-45638026-1", {"cookieDomain":"auto"});ga("set", "page", location.pathname + location.search + location.hash);ga("send", "pageview");ga('create', 'UA-189672-38', 'auto', {'name': 'hwTracker'});
ga('set', 'anonymizeIp', true);
ga('hwTracker.send', 'pageview');
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__1PtAOZ8x7l6QAi8D7X6Kj_Y7HcUOFzvWRvvYHUcCT98__U8IB92u_CnnGwJ-X_xaUa9lzsC8OzUfN0WkK2JQfirg__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings,{"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"jcore_1","theme_token":"yUwlOsVxuVEZCvKwBtreP7sTsULZNE--xDxDt0um1Ak","css":{"modules\/system\/system.base.css":1,"modules\/system\/system.menus.css":1,"modules\/system\/system.messages.css":1,"modules\/system\/system.theme.css":1,"misc\/ui\/jquery.ui.core.css":1,"misc\/ui\/jquery.ui.theme.css":1,"misc\/ui\/jquery.ui.button.css":1,"misc\/ui\/jquery.ui.resizable.css":1,"misc\/ui\/jquery.ui.dialog.css":1,"misc\/ui\/jquery.ui.tooltip.css":1,"modules\/comment\/comment.css":1,"sites\/all\/modules\/contrib\/date\/date_api\/date.css":1,"sites\/all\/modules\/contrib\/date\/date_popup\/themes\/datepicker.1.7.css":1,"modules\/field\/theme\/field.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_draw\/css\/highwire-draw.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_folders\/highwire_folders.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/css\/highwire-responsive.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_saved_searches\/highwire_saved_searches.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_user\/highwire_user.css":1,"modules\/node\/node.css":1,"modules\/search\/search.css":1,"modules\/user\/user.css":1,"modules\/forum\/forum.css":1,"sites\/all\/modules\/contrib\/views\/css\/views.css":1,"sites\/all\/modules\/contrib\/ckeditor\/css\/ckeditor.css":1,"sites\/all\/modules\/contrib\/colorbox\/styles\/default\/colorbox_style.css":1,"sites\/all\/modules\/contrib\/ctools\/css\/ctools.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire.style.highwire.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/nlm-elements.css":1,"sites\/all\/modules\/contrib\/panels\/css\/panels.css":1,"sites\/default\/modules\/biorxiv\/css\/biorxiv.css":1,"public:\/\/ctools\/css\/263bfdb18936424f0ade19d6bd885f37.css":1,"\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.css":1,"sites\/all\/modules\/contrib\/panels_ajax_tab\/css\/panels_ajax_tab.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire.style.markup.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/layouts\/highwire_2col_stacked\/highwire-2col-stacked.css":1,"sites\/all\/modules\/contrib\/forward\/forward.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/css\/highwire_share_link.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/css\/highwire_copy_permalink.css":1,"sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/flexible\/flexible.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_collection\/css\/highwire_subject_collection.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/highwire.highwire-list-expand.css":1,"public:\/\/ctools\/css\/bab59090150caf0c64e27afa1b36eef1.css":1,"sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/onecol\/onecol.css":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/css\/eu_cookie_compliance.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_theme_tools\/css\/font-hwicons.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_theme_tools\/css\/font-hwicons-glyphs.css":1,"0":1,"sites\/all\/themes\/highwire\/jcore_1\/eu_cookie_compliance.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/font-awesome-ie7.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-reset.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-mobile.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-alpha.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/formalize.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-text.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-branding.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-menu.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-forms.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/highwire-forms.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/mobile-reset.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/font-awesome.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/forms.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/global.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/jquery-ui-elements.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/text.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/colors.css.less":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-normal.css":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/normal\/jcore-default-normal-30.css":1,"narrow::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"narrow::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-narrow.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/narrow\/jcore-default-narrow-30.css":1,"normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-normal.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/normal\/jcore-default-normal-30.css":1,"wide::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"wide::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-wide.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/wide\/jcore-default-wide-30.css":1,"sites\/default\/modules\/jnl_biorxiv_styles\/css\/biorxiv-styles.css.less":1,"https:\/\/d33xdlntwy0kbs.cloudfront.net\/cshl_custom.css":1},"js":{"sites\/all\/libraries\/enquire.js\/enquire.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_panels_ajax_tab.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_openurl.js":1,"sites\/all\/libraries\/lazysizes\/lazysizes.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_figures.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_google_scholar_sprinkle.js":1,"http:\/\/d33xdlntwy0kbs.cloudfront.net\/cshl_custom.js":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/js\/eu_cookie_compliance.js":1,"sites\/default\/modules\/jnl_biorxiv_styles\/js\/adv-search-collection-toggle.js":1,"sites\/all\/libraries\/modernizr\/modernizr.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/jquery\/1.8\/jquery.min.js":1,"misc\/jquery-extend-3.4.0.js":1,"misc\/jquery.once.js":1,"misc\/drupal.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.core.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.widget.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.button.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.mouse.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.draggable.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.position.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.resizable.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.dialog.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.tooltip.min.js":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/js\/jquery.cookie-1.4.1.min.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.equal-heights.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.panels-ajax-tab.js":1,"sites\/default\/modules\/jnl_biorxiv_styles\/js\/biorxiv-scripts.js":1,"sites\/all\/libraries\/colorbox\/jquery.colorbox-min.js":1,"sites\/all\/modules\/contrib\/colorbox\/js\/colorbox.js":1,"sites\/all\/modules\/contrib\/colorbox\/styles\/default\/colorbox_style.js":1,"https:\/\/scholar.google.com\/scholar_js\/casa.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_log\/highwire_log.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_nps_survey\/js\/nps_survey.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_user\/js\/highwire_user_meta.js":1,"sites\/all\/modules\/contrib\/panels\/js\/panels.js":1,"\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.article-citation-author-tooltip.js":1,"sites\/all\/modules\/contrib\/panels_ajax_tab\/js\/panels_ajax_tab.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_article_reference_popup.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_at_symbol.js":1,"sites\/default\/modules\/contrib\/disqus\/disqus.js":1,"misc\/textarea.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_share_dialog.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/clipboard.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_clipboard.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_citation\/plugins\/content_types\/js\/highwire_citation_export.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/minipanel_dialog_link.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/twitter_button.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/facebook_like.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/google_plus_one.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.highwire-list-expand.js":1,"sites\/all\/modules\/contrib\/google_analytics\/googleanalytics.js":1,"sites\/all\/themes\/highwire\/jcore_1\/js\/theme-scripts.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/jquery.formalize.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/omega-mediaqueries.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/omega-equalheights.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/js\/highwire-mediaqueries.js":1}},"colorbox":{"opacity":"0.85","current":"{current} of {total}","previous":"\u00ab Prev","next":"Next \u00bb","close":"Close","maxWidth":"98%","maxHeight":"98%","fixed":true,"mobiledetect":true,"mobiledevicewidth":"480px"},"highwire":{"nid":"596459","apath":"\/biorxiv\/early\/2019\/04\/12\/606715.atom","pisa":"biorxiv;606715v1","processed":["highwire_math"],"markup":[{"requested":"full-text","variant":"full-text","view":"full","pisa":"biorxiv;606715v1"}],"modal_window_width":"560","share_modal_width":"560","share_modal_title":"Share this Article"},"jcarousel":{"ajaxPath":"\/jcarousel\/ajax\/views"},"instances":"{\u0022highwire_abstract_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:20,\u0022height\u0022:20,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-abstract-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-abstract-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022right center\u0022,\u0022my\u0022:\u0022left center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022shift\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter click \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_author_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-author-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-author-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022top center\u0022,\u0022my\u0022:\u0022bottom center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_reflinks_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022mimic\u0022:\u0022top center\u0022,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-ref-link-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-ref-link-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022bottom left\u0022,\u0022my\u0022:\u0022top left\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022flip\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}}}","qtipDebug":"{\u0022leaveElement\u0022:0}","panel_ajax_tab":{"path":"sites\/all\/modules\/contrib\/panels_ajax_tab"},"disqus":{"domain":"biorxivstage","url":"https:\/\/www.biorxiv.org\/content\/10.1101\/606715v1","title":"More than efficacy revealed by single-cell analysis of antiviral therapeutics","identifier":"node\/596459"},"panels_ajax_pane":{"new-41":"{\u0022encrypted\u0022:\u0022{\\\u0022encrypted\\\u0022:\\\u0022NCQpMWbH18ukwi3GpC+YEIVOFIF\\\\\\\/v9vuuLLT6tzo2w3eFvhn1ZI0dT4xQPnZGGoxa5f4vvpOwyW38bFvQeEMRY4VCMKZ3dKkfWoO8MoTia90U5Q9Kh5StaAsqyDJt2pksR\\\\\\\/dsbqEOBuBd73yMUFq27aWkHwxhGLoKl07FxRk8g20VId95aZR2nKjG7vddjf8om9pBv8xvrACHuyLMFeO70Yr5aDhlL328KaseQmPP6Q5RG8rT\\\\\\\/SZbDTsEa+x92BwVeY1XkArmGJCbv14nCX5Pm5Rr8qncCgUO5TRfZlWm0lPfvJhVIZtFyJhVRXx6BgENwlfsWCqkH2toFAdCAsIDVKObu8PGN+dPVGSx23K\\\\\\\/5jSkMfwHjnl8g+dxgnUqRpcxtUYiYTlKVcOYZ5NMhNz66yufksF+zWSGsV69qEruKAxKdFNLFb8B1XL6MqGH+TlPQU0FW8I41lH2Oiq0plQ9UNOuouFWll5jlxo28jgvUwO6pQv0pnDyuxuEPvlaVo2PcoyrpAUlefnQdCD4y0Afb73tXLu\\\\\\\/JzfSDvVdnmufWgnGNxz6Il2fOM+3kCPYMgRbKAahH7QXdfNF7EiSNCTmOXWrjTKHdvoc1bnJhTrW+065tENWLfTkUh87vz6+uQ8pgD2zsuTA3KN705p15WqRfaTAXP8EoMClMJ8Zhfkcq1Bw0enOAnTo8vUO9DvhOjGmQuPwYms9RrUVE+Zw6d62uFDlGsoqe1SgbrNeh2yive8jkQ\\\\\\\/JH5Em3eL4ex\\\\\\\/2C7yZKopEy\\\\\\\/l6v2W0MiKnVPFSSa1nePq96aHhWTpdqnCDLzbl0KP\\\\\\\/kRo+ophCkkXFpNvoeyCzpmyVlezNWnfn4Ge0SJ3hQo962sF7MUO8vUcg7+fDfrVZ5bI4zUNFE8Cy6B9N9\\\\\\\/0JQ0FRHDWOD0inHK5FxwhHna1poQKNQ+w5Yrq6c3XQf+NMVmFxi6KD4\\\\\\\/NxNN3c4zLfqtfqfcxi5xedrAKMg3grllcjXB\\\\\\\/DFarwIMxGAlR\\\\\\\/L9p8BlKfhG5BhBFlaJ8gSK\\\\\\\/vR1ZFK7USfDEn0GKChYsY7\\\\\\\/WuZPdBfFEEVGh7QSM031WWmlmBtGTNdxbz8YNZOjcoZWqBqsOqAG0QKQFLTSiyEaNH4k+h0QbRWJVqAbVvOWOZzW1SfuTTMcxgMmCfQNZBoMKPQdguc6JVMsFLgySspLNpkdrFHgnjRjQZGFxny2w3tnY2IPrlGZdGXKhkhpfgD\\\\\\\/trNkFOP0DLlwTBEDBXvkylcQ\\\\\\\/5ZL\\\\\\\/hIZbvnE9SVIjczXFiCx+IdfgWWXEv\\\\\\\/HWjTokx6b1Wsr2wu4SGJGqIUkNGdUEnGmBUNkqqUA=\\\u0022,\\\u0022iv\\\u0022:\\\u0022xlvnRz2bJcANRNvxl6XT5A==\\\u0022,\\\u0022salt\\\u0022:\\\u0022f9d8845712f72c9fee5db7d9ff111eab\\\u0022}\u0022,\u0022hmac\u0022:\u0022a24b9f4e9da1f93d4850fa17f14ba3b6581acf57cb253af92f2958661cbf0f10\u0022}"},"urlIsAjaxTrusted":{"\/content\/10.1101\/606715v1.full":true},"ws_fl":{"width":100,"height":21},"ws_gpo":{"size":"","annotation":"","lang":"","callback":"","width":300},"color":{"logo":"https:\/\/www.biorxiv.org\/sites\/default\/files\/bioRxiv_article.jpg"},"highwire_list_expand":{"is_collapsed":"1"},"highwireResponsive":{"enquire_enabled":1,"breakpoints_configured":1,"breakpoints":{"zero":"all and (min-width: 0px)","xsmall":"all and (min-width: 380px)","narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}},"eu_cookie_compliance":{"popup_enabled":1,"popup_agreed_enabled":0,"popup_hide_agreed":0,"popup_clicking_confirmation":1,"popup_scrolling_confirmation":false,"popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003EWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","use_mobile_message":false,"mobile_popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n          \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","mobile_breakpoint":"768","popup_html_agreed":"\u003Cdiv\u003E\n  \u003Cdiv class=\u0022popup-content agreed\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Ch2\u003EThank you for accepting cookies\u003C\/h2\u003E\u003Cp\u003EYou can now hide this message or find out more about cookies.\u003C\/p\u003E    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022hide-popup-button eu-cookie-compliance-hide-button\u0022\u003EHide\u003C\/button\u003E\n              \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button-thank-you\u0022 \u003EMore info\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","popup_use_bare_css":false,"popup_height":"auto","popup_width":"100%","popup_delay":1000,"popup_link":"\/help\/cookie-policy","popup_link_new_window":1,"popup_position":null,"popup_language":"en","store_consent":false,"better_support_for_screen_readers":0,"reload_page":0,"domain":"","popup_eu_only_js":0,"cookie_lifetime":"365","cookie_session":false,"disagree_do_not_show_popup":0,"method":"default","whitelisted_cookies":"","withdraw_markup":"\u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-tab\u0022\u003EPrivacy settings\u003C\/button\u003E\n\u003Cdiv class=\u0022eu-cookie-withdraw-banner\u0022\u003E\n  \u003Cdiv class=\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003E\u0026lt;h2\u0026gt;We use cookies on this site to enhance your user experience\u0026lt;\/h2\u0026gt;\u0026lt;p\u0026gt;You have given your consent for us to set cookies.\u0026lt;\/p\u0026gt;\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-button\u0022\u003EWithdraw consent\u003C\/button\u003E\n    \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","withdraw_enabled":false},"googleanalytics":{"trackOutbound":1,"trackMailto":1,"trackDownload":1,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip","trackColorbox":1,"trackUrlFragments":1},"jnl_biorxiv_styles":{"defaultJCode":"biorxiv"},"omega":{"layouts":{"primary":"normal","order":["narrow","normal","wide"],"queries":{"narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}}}});
//--><!]]>
</script>
    <!--[if lt IE 9]><script src="http://html5shiv.googlecode.com/svn/trunk/html5.js"></script><![endif]-->
  </head>
  <body class="html not-front not-logged-in page-node page-node- page-node-596459 node-type-highwire-article context-content hw-default-jcode-biorxiv hw-article-type-article hw-article-category-new-results">
<!-- Google Tag Manager -->
<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-M677548" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<script type="text/javascript">(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-M677548');</script>
<!-- End Google Tag Manager -->
    <div id="skip-link">
      <a href="#main-content" class="element-invisible element-focusable">Skip to main content</a>
    </div>
        <div class="page clearfix page-box-shadows footer-borders panels-page panels-layout-jcore_2col" id="page">
      <header id="section-header" class="section section-header">
    
  <div id="zone-branding" class="zone zone-branding clearfix print-display-block container-30">
    <div class="grid-15 prefix-1 region region-branding print-display-block" id="region-branding">
  <div class="region-inner region-branding-inner">
        <div class="branding-data clearfix">
            <div class="logo-img">
        <a href="/" rel="home" class="" data-icon-position="" data-hide-link-title="0"><img alt="bioRxiv" src="https://www.biorxiv.org/sites/default/files/bioRxiv_article.jpg" /></a>      </div>
                </div>
          </div>
</div><div class="grid-11 suffix-1 region region-branding-second print-hidden" id="region-branding-second">
  <div class="region-inner region-branding-second-inner">
    <div class="block block-system block-menu block-main-menu block-system-main-menu odd block-without-title" id="block-system-main-menu">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf" role="menuitem"><a href="/" title="" class="" data-icon-position="" data-hide-link-title="0">Home</a></li>
<li class="leaf" role="menuitem"><a href="/about-biorxiv" class="" data-icon-position="" data-hide-link-title="0">About</a></li>
<li class="leaf" role="menuitem"><a href="/submit-a-manuscript" class="" data-icon-position="" data-hide-link-title="0">Submit</a></li>
<li class="last leaf" role="menuitem"><a href="/content/alertsrss" title="" class="" data-icon-position="" data-hide-link-title="0">ALERTS / RSS</a></li>
</ul></nav>    </div>
  </div>
</div><div class="block block-panels-mini block-biorxiv-search-box block-panels-mini-biorxiv-search-box even block-without-title" id="block-panels-mini-biorxiv-search-box">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_search_box">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-seach-quicksearch" >
  
      
  
  <div class="pane-content">
    <form class="highwire-quicksearch button-style-mini button-style-mini" action="/content/10.1101/606715v1.full" method="post" id="highwire-search-quicksearch-form-0" accept-charset="UTF-8"><div><div class="form-item form-item-label-invisible form-type-textfield form-item-keywords">
  <label class="element-invisible" for="edit-keywords">Search for this keyword </label>
 <input placeholder="Search" type="text" id="edit-keywords" name="keywords" value="" size="60" maxlength="128" class="form-text" />
</div>
<div class="button-wrapper button-mini"><i class="icon-search"></i><input data-icon-only="1" data-font-icon="icon-search" data-icon-position="after" type="submit" id="edit-submit--2" name="op" value="Search" class="form-submit" /></div><input type="hidden" name="form_build_id" value="form-6TobJ32yA4jRwtgcITiLx5TPAVq_sJ34L37WgY6LAA4" />
<input type="hidden" name="form_id" value="highwire_search_quicksearch_form_0" />
</div></form>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-2 advanced-search-link" >
  
      
  
  <div class="pane-content">
    <a href="/search">Advanced Search</a>  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div>  </div>
  
  <div id="zone-header" class="zone zone-header clearfix container-30">
  	      </div>
</header>    
      <section id="section-content" class="section section-content">
    
  <div id="zone-content" class="zone zone-content clearfix container-30">    
        
    <div class="grid-28 suffix-1 prefix-1 region region-content" id="region-content">
  <div class="region-inner region-content-inner">
    <a id="main-content"></a>
                        <div class="block block-system block-main block-system-main odd block-without-title" id="block-system-main">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panels-960-layout jcore-2col-layout" >
	  
  <div class="panel-row-wrapper clearfix">
		
		<div class="main-content-wrapper grid-17 suffix-1 alpha">
			<div class="panel-panel panel-region-content">
			  <div class="inside"><div class="panel-pane pane-highwire-article-citation" >
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="596459" id="node596459" data-pisa="biorxiv;606715v1" data-pisa-master="biorxiv;606715" data-apath="/biorxiv/early/2019/04/12/606715.atom" data-hw-author-tooltip-instance="highwire_author_tooltip"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-top clearfix has-author-tooltip" >

      <span class="biorxiv-article-type">
        New Results    </span>
  
        <h1 class="highwire-cite-title" id="page-title">More than efficacy revealed by single-cell analysis of antiviral therapeutics</h1>  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Wu</span> <span class="nlm-surname">Liu</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Mehmet U.</span> <span class="nlm-surname">Caglar</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Zhangming</span> <span class="nlm-surname">Mao</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Andrew</span> <span class="nlm-surname">Woodman</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Jamie J.</span> <span class="nlm-surname">Arnold</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">Claus O.</span> <span class="nlm-surname">Wilke</span></span>, <span class="highwire-citation-author" data-delta="6"><span class="nlm-given-names">Craig E.</span> <span class="nlm-surname">Cameron</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="label">doi:</span> https://doi.org/10.1101/606715 </span></div>
  
  
  </div>
<div id="hw-article-author-popups-node596459" style="display: none;"><div class="author-tooltip-0"><div class="author-tooltip-name">Wu Liu </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park</span>, Pennsylvania 16802, <span class='nlm-country'>United States</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Wu%2BLiu%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Liu%20W&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link"><a href="/search/author1%3AWu%2BLiu%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li><li class="author-corresp-email-link last"><span>For correspondence: 
<a href="mailto:wul28@psu.edu" class="" data-icon-position="" data-hide-link-title="0">wul28@psu.edu</a>
<a href="mailto:cec9@psu.edu" class="" data-icon-position="" data-hide-link-title="0">cec9@psu.edu</a></span></li></ul></div><div class="author-tooltip-1"><div class="author-tooltip-name">Mehmet U. Caglar </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>3</span><span class='nlm-institution'>Center for Computational Biology and Bioinformatics, Institute for Cellular and Molecular Biology, and Department of Integrative Biology, The University of Texas at Austin</span>, Austin, Texas 78712, <span class='nlm-country'>United States</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Mehmet%2BU.%2BCaglar%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Caglar%20MU&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AMehmet%2BU.%2BCaglar%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-2"><div class="author-tooltip-name">Zhangming Mao </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>2</span><span class='nlm-institution'>Department of Engineering Science and Mechanics, The Pennsylvania State University, University Park</span>, Pennsylvania 16802, <span class='nlm-country'>United States</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Zhangming%2BMao%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Mao%20Z&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AZhangming%2BMao%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-3"><div class="author-tooltip-name">Andrew Woodman </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park</span>, Pennsylvania 16802, <span class='nlm-country'>United States</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Andrew%2BWoodman%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Woodman%20A&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AAndrew%2BWoodman%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-4"><div class="author-tooltip-name">Jamie J. Arnold </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park</span>, Pennsylvania 16802, <span class='nlm-country'>United States</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Jamie%2BJ.%2BArnold%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Arnold%20JJ&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AJamie%2BJ.%2BArnold%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-5"><div class="author-tooltip-name">Claus O. Wilke </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>3</span><span class='nlm-institution'>Center for Computational Biology and Bioinformatics, Institute for Cellular and Molecular Biology, and Department of Integrative Biology, The University of Texas at Austin</span>, Austin, Texas 78712, <span class='nlm-country'>United States</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Claus%2BO.%2BWilke%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Wilke%20CO&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AClaus%2BO.%2BWilke%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-6"><div class="author-tooltip-name">Craig E. Cameron </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park</span>, Pennsylvania 16802, <span class='nlm-country'>United States</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Craig%2BE.%2BCameron%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Cameron%20CE&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link"><a href="/search/author1%3ACraig%2BE.%2BCameron%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li><li class="author-corresp-email-link last"><span>For correspondence: 
<a href="mailto:wul28@psu.edu" class="" data-icon-position="" data-hide-link-title="0">wul28@psu.edu</a>
<a href="mailto:cec9@psu.edu" class="" data-icon-position="" data-hide-link-title="0">cec9@psu.edu</a></span></li></ul></div></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs pane-panels-ajax-tab-tabs" >
  
      
  
  <div class="pane-content">
    <div class="item-list"><ul class="tabs inline panels-ajax-tab"><li class="first"><a href="/content/10.1101/606715v1" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_art" data-target-id="highwire_article_tabs" data-entity-context="node:596459" data-trigger="" data-url-enabled="1">Abstract</a><a href="/panels_ajax_tab/biorxiv_tab_art/node:596459/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/606715v1.full-text" class="panels-ajax-tab-tab" data-panel-name="article_tab_full_text" data-target-id="highwire_article_tabs" data-entity-context="node:596459" data-trigger="full-text" data-url-enabled="1">Full Text</a><a href="/panels_ajax_tab/article_tab_full_text/node:596459/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/606715v1.article-info" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_info" data-target-id="highwire_article_tabs" data-entity-context="node:596459" data-trigger="article-info" data-url-enabled="1">Info/History</a><a href="/panels_ajax_tab/biorxiv_tab_info/node:596459/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/606715v1.article-metrics" class="panels-ajax-tab-tab" data-panel-name="article_tab_metrics" data-target-id="highwire_article_tabs" data-entity-context="node:596459" data-trigger="article-metrics" data-url-enabled="1">Metrics</a><a href="/panels_ajax_tab/article_tab_metrics/node:596459/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/606715v1.supplementary-material" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_data" data-target-id="highwire_article_tabs" data-entity-context="node:596459" data-trigger="supplementary-material" data-url-enabled="1">Supplementary material</a><a href="/panels_ajax_tab/biorxiv_tab_data/node:596459/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li class="last"><a href="/content/10.1101/606715v1.full.pdf+html" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_pdf" data-target-id="highwire_article_tabs" data-entity-context="node:596459" data-trigger="full.pdf+html" data-url-enabled="1"><i class="icon-file-alt"></i> Preview PDF</a><a href="/panels_ajax_tab/biorxiv_tab_pdf/node:596459/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li></ul></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs-container" >
  
      
  
  <div class="pane-content">
    <div data-panels-ajax-tab-preloaded="article_tab_full_text" id="panels-ajax-tab-container-highwire_article_tabs" class="panels-ajax-tab-container"><div class="panels-ajax-tab-loading" style ="display:none"><img class="loading" src="https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif" alt="Loading" title="Loading" /></div><div class="panels-ajax-tab-wrap-article_tab_full_text"><div class="panel-display panel-1col clearfix" >
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-markup" >
  
      
  
  <div class="pane-content">
    <div class="highwire-markup"><div xmlns="http://www.w3.org/1999/xhtml" id="content-block-markup" data-highwire-cite-ref-tooltip-instance="highwire_reflinks_tooltip" xmlns:xhtml="http://www.w3.org/1999/xhtml"><div class="article fulltext-view "><span class="highwire-journal-article-marker-start"></span><div class="section abstract" id="abstract-1"><h2 class="">SUMMARY</h2><p id="p-2">Development of antiviral therapeutics emphasizes minimization of the effective dose and maximization of the toxic dose, first in cell culture and later in animal models. Long-term success of an antiviral therapeutic is determined not only by its efficacy but also by the duration of time required for drug-resistance to evolve. We have developed a microfluidic device comprised of ~6000 wells, with each well containing a microstructure to capture single cells. We have used this device to characterize enterovirus inhibitors with distinct mechanisms of action. In contrast to population methods, single-cell analysis reveals that each class of inhibitor interferes with the viral infection cycle in a manner that can be distinguished by principal component analysis. Single-cell analysis of antiviral candidates reveals not only efficacy but also properties of the members of the viral population most sensitive to the drug, the stage of the lifecycle most affected by the drug, and perhaps even if the drug targets an interaction of the virus with its host.</p></div><div class="section" id="sec-1"><h2 class="">INTRODUCTION</h2><p id="p-3">Over the past few decades, the world has witnessed outbreaks of myriad RNA viruses, including West Nile Virus, severe acute respiratory syndrome (SARS) coronavirus, chikungunya virus, Ebola virus, Zika virus, and most recently the poliovirus (PV)-related viruses: enterovirus D68 (EV-D68) and enterovirus A71 (EV-A71) (<a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">Antona et al., 2016</a>; <a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">Baize et al., 2014</a>; <a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">Burt et al., 2012</a>; <a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">Campbell et al., 2002</a>; <a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">Campos et al., 2015</a>; <a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">Peiris et al., 2003</a>). Unfortunately, viral emergence has outpaced the discovery and development of compounds capable of treating these pathogens. Because sporadic outbreaks come, go, and may never come again, development of broad-spectrum therapeutics exhibiting high barriers to resistance would have the greatest value. Unbiased screening of chemical libraries for antiviral agents using cell-based assays have no problem identifying active compounds of high potency. However, identifying the target and predicting the likelihood for evolution of resistance generally takes years of effort following compound discovery.</p><p id="p-4">As a part of a study evaluating PV infection dynamics on the single-cell level, we observed that a chain-terminating antiviral ribonucleotide selectively eliminates the most-fit members of the viral population (<a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">Guo et al., 2017</a>). This class of antiviral agent has always been touted as having a high barrier to resistance (<a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">Jordheim et al., 2013</a>). The typical explanation for this high barrier is that amino acid substitutions in the active site of the viral RNA polymerase conferring resistance to the antiviral ribonucleoside also impair the specificity and/or efficiency of incorporation of natural ribonucleotides (<a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">Carroll et al., 2003</a>). Elimination of the most-fit members of the viral population by an antiviral agent requires that resistance emerge from the surviving, low-fitness member of the population, which would ultimately require restoration of fitness for the population to survive the myriad mechanisms of host restriction (<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">Andino and Domingo, 2015</a>). Restoration of fitness may be the insurmountable barrier precluding the development of resistance to chain-terminating antiviral ribonucleotides.</p><p id="p-5">This study was designed to determine the extent to which single-cell analysis of antiviral agents can contribute to our understanding of antiviral therapeutics relative to traditional approaches. We describe a microfluidics device that can be used to produce complete dose-response curves. We have used this device to compare three, mechanistically-distinct classes of antiviral agents: a PV polymerase inhibitor (2’-<em>C</em>-methyl-adenosine, 2’-<em>C</em>-Me-A); a PV protease inhibitor (rupintrivir); and two HSP90 inhibitors (geldanamycin, GA, and ganetespib, GS). We find that single-cell analysis distinguishes these classes of inhibitors. We suggest that addition of single-cell analysis to the existing paradigm for preclinical development of antiviral therapies may have the potential to identify leads with limited potential for development of resistance.</p></div><div class="section" id="sec-2"><h2 class="">RESULTS</h2><div id="sec-3" class="subsection"><h3>A device for single-cell analysis of the activity of antiviral agents</h3><p id="p-6">Our initial foray into single-cell analysis of PV infection dynamics used cell density to control single-cell occupancy of wells of a microfluidic device (<a id="xref-ref-20-2" class="xref-bibr" href="#ref-20">Guo et al., 2017</a>). What this means practically is that most wells are empty. Reducing the number of events monitored by a mere factor of two takes us below the number of events required for statistical analysis of the data. Acquisition of a dose-response curve was therefore impossible using this first-generation device.</p><p id="p-7">To address this problem, we created a multi-layer device as previously described (<strong><a id="xref-fig-1-1" class="xref-fig" href="#F1">Fig. 1a</a></strong>) (<a id="xref-ref-20-3" class="xref-bibr" href="#ref-20">Guo et al., 2017</a>) but added a trapping structure to the channel layer of the device (<strong><a id="xref-fig-1-2" class="xref-fig" href="#F1">Figs. 1b</a></strong> and <strong>S1a</strong>). Position of the trapping structure was guided by simulation (<strong><a id="xref-fig-1-3" class="xref-fig" href="#F1">Fig. 1c</a></strong>), leading to placement of the trapping structure on the rear wall of each well (<strong><a id="xref-fig-1-4" class="xref-fig" href="#F1">Fig. 1d</a></strong>). The device contains five independent zones, each containing 1140 wells for a total of 5700 wells. The device mounts easily to the stage of a microscope (<strong>Fig. S1b</strong>); the device in cross-section is shown in <strong>Fig. S2</strong>. Single-cell occupancy of the device was sensitive to the width of the channels used for loading (<strong>Fig. S3a</strong>) and cell density (<strong>Fig. S3b</strong>) with maximum occupancy near 90% (<strong><a id="xref-fig-1-5" class="xref-fig" href="#F1">Figs. 1d</a></strong> and <strong>S3</strong>). Under conditions in which an inhibitor reduces infection to 10%, ~100 infected cells will be observed using this device. This number of events is more than enough for statistical analysis.</p><div id="F1" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F1.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Addition of cell-trapping microstructures to wells of a microfluidic device enhances single-cell occupancy. (a) Schematic of the device. The following layers exist: microwell (not shown explicitly); channel (green); and valve (cyan). The device is divided into five sections of 1140 microwells (different shades of green for the channel layer), for a total of 5700 microwells. (b) Schematic of two wells of the device with all relevant dimensions indicated. The microwell layer creates a physical barrier between adjacent wells. The barrier between adjacent wells is sealed with water emanating from the valve layer. Water in valve layer is sealed by application of air under pressure (20-30 psi). (c) Simulation of the flow velocity field in a microwell indicated that the outlet would maximize cell trapping by the microstructure. (d) Image showing cells captured by the microstructures in the microwells. The device was infused with cells (5 &#xD7; 105 cells/mL) at rate of 0.5 &#x3BC;L/min. Under optimal conditions, 86.1% (4902) microwells of the device contained single cells." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-353495974" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;&lt;span class=&quot;caption-title&quot;&gt;Addition of cell-trapping microstructures to wells of a microfluidic device enhances single-cell occupancy.&lt;/span&gt; (&lt;strong&gt;a&lt;/strong&gt;) Schematic of the device. The following layers exist: microwell (not shown explicitly); channel (green); and valve (cyan). The device is divided into five sections of 1140 microwells (different shades of green for the channel layer), for a total of 5700 microwells. (&lt;strong&gt;b&lt;/strong&gt;) Schematic of two wells of the device with all relevant dimensions indicated. The microwell layer creates a physical barrier between adjacent wells. The barrier between adjacent wells is sealed with water emanating from the valve layer. Water in valve layer is sealed by application of air under pressure (20-30 psi). (&lt;strong&gt;c&lt;/strong&gt;) Simulation of the flow velocity field in a microwell indicated that the outlet would maximize cell trapping by the microstructure. (&lt;strong&gt;d&lt;/strong&gt;) Image showing cells captured by the microstructures in the microwells. The device was infused with cells (5 &#xD7; 10&lt;sup&gt;5&lt;/sup&gt; cells/mL) at rate of 0.5 &#x3BC;L/min. Under optimal conditions, 86.1% (4902) microwells of the device contained single cells.&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 1." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F1.medium.gif" width="440" height="257"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 1." src="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F1.medium.gif" width="440" height="257"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F1.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 1." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F1.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption" xmlns:xhtml="http://www.w3.org/1999/xhtml"><span class="fig-label">Figure 1.</span> <span class="caption-title">Addition of cell-trapping microstructures to wells of a microfluidic device enhances single-cell occupancy.</span><p id="p-8" class="first-child">(<strong>a</strong>) Schematic of the device. The following layers exist: microwell (not shown explicitly); channel (green); and valve (cyan). The device is divided into five sections of 1140 microwells (different shades of green for the channel layer), for a total of 5700 microwells. (<strong>b</strong>) Schematic of two wells of the device with all relevant dimensions indicated. The microwell layer creates a physical barrier between adjacent wells. The barrier between adjacent wells is sealed with water emanating from the valve layer. Water in valve layer is sealed by application of air under pressure (20-30 psi). (<strong>c</strong>) Simulation of the flow velocity field in a microwell indicated that the outlet would maximize cell trapping by the microstructure. (<strong>d</strong>) Image showing cells captured by the microstructures in the microwells. The device was infused with cells (5 × 10<sup>5</sup> cells/mL) at rate of 0.5 μL/min. Under optimal conditions, 86.1% (4902) microwells of the device contained single cells.</p><div class="sb-div caption-clear"></div></div></div></div><div id="sec-4" class="subsection"><h3>Re-evaluation of a PV polymerase inhibitor</h3><p id="p-9">Viral polymerases represent a well-established target of antiviral therapeutics. For example, cocktails used to treat human immunodeficiency virus infection and hepatitis C virus (HCV) infection include synthetic nucleoside analogues targeting reverse transcriptase and RNA-dependent RNA polymerase (RdRp), respectively (<a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">Cihlar and Ray, 2010</a>; <a id="xref-ref-32-1" class="xref-bibr" href="#ref-32">Sofia et al., 2012</a>). The non-obligate, chain-terminating antiviral ribonucleoside, 2’-<em>C</em>-Me-A, is the prototype for the HCV RdRp inhibitor, sofosbuvir and related compounds (<a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">Eltahla et al., 2015</a>). In a previous study, we evaluated infections that survived treatment when present at a concentration that reduces the number of infections by 50% (IC50). To our surprise, we observed selective ablation of cells infected with virus variants capable of the fastest rates of replication and the highest yields of replicated RNA (<a id="xref-ref-20-4" class="xref-bibr" href="#ref-20">Guo et al., 2017</a>). This experiment suffered from the inability to evaluate concentrations of drug higher than the value of the IC50. Here, we use 2’-<em>C</em>-Me-A to validate the new device.</p><p id="p-10">For all experiments reported herein, we infect HeLa S3 cells off chip with PV engineered to express enhanced green fluorescent protein (PV-eGFP) at a multiplicity of infection of 0.5 plaque-forming units per cell (PFU/cell), pellet and wash cells to remove free virus, suspend cells to a density of 5 × 10<sup>5</sup> cells/mL, and load the microfluidic device. Each well is monitored for eGFP fluorescence every 30 min for a 24 h period, which gives rise to a population of time courses exhibiting substantial between-cell variability (<strong>Fig. S4a</strong>). We plot the percentage of infected cells as a function of drug concentration and fit to a hyperbola to obtain a value for the IC50 value. In the case of 2’-<em>C</em>-Me-A, concentrations greater than 50 µM exhibit toxicity (<a id="xref-ref-33-1" class="xref-bibr" href="#ref-33">Stuyver et al., 2006</a>); therefore, these data do not fit to a hyperbola (<strong>Fig. S4b</strong>). It is clear from this experiment, however, that the approach is sensitive enough to acquire data for a complete dose-response analysis (<strong>Fig S4b</strong>).</p><p id="p-11">A major advantage of the single-cell platform is that the effect of a drug on the viable population can be determined. To analyze the single-cell data, we use five phenomenological parameters extracted from each time course (<strong>Fig. S4c</strong>). These parameters are: <em>maximum</em> fluorescence observed, which correlates to yield of genomic RNA; <em>slope</em> at the time of half-maximum fluorescence, which correlates to replication speed; <em>infection time</em>, which, to a first approximation, is the time it takes for an infection to go from start to finish akin to the virus generation time; <em>start-point</em>, which is the earliest time in which fluorescence can be detected; and <em>midpoint</em>, the time of half-maximum fluorescence. This analysis leads to a distribution of values formed from values measured in each cell. Our statistical analysis uses an unpaired two-tailed t-test to determine if a significant difference exists for the means of a given parameter under two experimental conditions. In these experiments, the area under the curve defining the distribution reflects the number of events monitored. We do not attempt to interpret a difference in the “fine” structure of the distributions.</p><p id="p-12">Using this data-analysis pipeline to evaluate outcomes in the absence and presence of 2’- <em>C</em>-Me-A (50 µM), we observed a statistically significant difference in the mean values for the maximum (<strong>Fig. S4d</strong>) and slope (<strong>Fig. S4e</strong>) parameters without a statistically significant change in the mean values for the remaining parameters (<strong>Figs. S4f</strong> - <strong>S4h</strong>). Tabulation of the data and statistical analysis for this experiment is provided in <strong>Tables S1</strong> and <strong>S2</strong>. These observations reproduce outcomes presented by us previously using the first-generation device (<a id="xref-ref-20-5" class="xref-bibr" href="#ref-20">Guo et al., 2017</a>). Members of the viral population with highest values for maximum and slope parameters are most sensitive to 2’-<em>C</em>-Me-A.</p></div><div id="sec-5" class="subsection"><h3>Evaluation of a PV 3C-protease inhibitor</h3><p id="p-13">The observation that a subset of the viral population was most sensitive to 2’-<em>C</em>-Me-A was unexpected but could be easily rationalized by the notion that increased replication efficiency should correlate to increased 2’-<em>C</em>-Me-AMP incorporation efficiency. Do inhibitors of other viral enzymes exhibit the same selectivity? Proteases of retroviruses and positive-sense RNA viruses responsible for polyprotein processing represent a second category of well-established antiviral therapeutics used in the cocktails to treat HIV and HCV, respectively (<a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">de Leuw and Stephan, 2018</a>; <a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">Pokorna et al., 2009</a>; <a id="xref-ref-37-1" class="xref-bibr" href="#ref-37">Wlodawer and Vondrasek, 1998</a>). Inhibitors of the picornaviral protease responsible for polyprotein processing (3C) have been pursued for many years (<a id="xref-ref-34-1" class="xref-bibr" href="#ref-34">Wang and Liang, 2010</a>). For this study, we selected rupintrivir, which targets the 3C protease activity of all three types of polioviruses as well as that of other enteroviruses (<a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">Binford et al., 2005</a>; <a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">De Palma et al., 2008</a>).</p><p id="p-14">We measured the impact of rupintrivir on establishment of PV infection in HeLa S3 cells (<strong><a id="xref-fig-2-1" class="xref-fig" href="#F2">Fig. 2a</a></strong>). The IC50 value was 8.0 ± 4.0 nM, which agrees with values (20 nM) measured using conventional plaque assays (<a id="xref-ref-14-2" class="xref-bibr" href="#ref-14">De Palma et al., 2008</a>). We analyzed the single-cell data obtained at all concentrations (<strong>Tables S3</strong> and <strong>S4</strong>) but focused only on the concentrations approximating the IC50 and 2 × IC50, 10 nM and 20 nM, respectively, to emphasize trends in the data. At both concentrations, we observed a statistically significant difference compared to the control for all parameters: maximum (<strong><a id="xref-fig-2-2" class="xref-fig" href="#F2">Fig. 2b</a></strong>); slope (<strong><a id="xref-fig-2-3" class="xref-fig" href="#F2">Fig. 2c</a></strong>); infection time (<strong><a id="xref-fig-2-4" class="xref-fig" href="#F2">Fig. 2d</a></strong>); start point (<strong><a id="xref-fig-2-5" class="xref-fig" href="#F2">Fig. 2e</a></strong>); and midpoint (<strong><a id="xref-fig-2-6" class="xref-fig" href="#F2">Fig. 2f</a></strong>). This outcome with rupintrivir is clearly distinct from that above with 2’- <em>C</em>-Me-A. We conclude that not all antiviral agents interfere with the viral population in the same manner or at the same stage(s) of the lifecycle.</p><div id="F2" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F2.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Evaluation of rupintrivir, a PV 3C protease inhibitor. (a) Dose-response analysis. Percentage of single, infected (green) cells was determined as a function of rupintrivir concentration. (b-f) Distributions for each parameter in the presence of 10 or 20 nM rupintrivir were compared to that in the absence of drug using a t-test. A single asterisk indicates a p-value less than 0.05; two asterisks indicate a p-value is less than 0.005. Numerical values for experimental parameters are provided in Table S3 and statistical analysis in Table S4. The parameters presented in the panels are as follows: (b) maximum; (c) slope; (d) infection time; (e) start point; (f) midpoint." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-353495974" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;&lt;span class=&quot;caption-title&quot;&gt;Evaluation of rupintrivir, a PV 3C protease inhibitor.&lt;/span&gt; (&lt;strong&gt;a&lt;/strong&gt;) Dose-response analysis. Percentage of single, infected (green) cells was determined as a function of rupintrivir concentration. (&lt;strong&gt;b&lt;/strong&gt;-&lt;strong&gt;f&lt;/strong&gt;) Distributions for each parameter in the presence of 10 or 20 nM rupintrivir were compared to that in the absence of drug using a t-test. A single asterisk indicates a p-value less than 0.05; two asterisks indicate a p-value is less than 0.005. Numerical values for experimental parameters are provided in &lt;strong&gt;Table S3&lt;/strong&gt; and statistical analysis in &lt;strong&gt;Table S4&lt;/strong&gt;. The parameters presented in the panels are as follows: (&lt;strong&gt;b&lt;/strong&gt;) maximum; (&lt;strong&gt;c&lt;/strong&gt;) slope; (&lt;strong&gt;d&lt;/strong&gt;) infection time; (&lt;strong&gt;e&lt;/strong&gt;) start point; (&lt;strong&gt;f&lt;/strong&gt;) midpoint.&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 2." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F2.medium.gif" width="369" height="440"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 2." src="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F2.medium.gif" width="369" height="440"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F2.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 2." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F2.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">Figure 2.</span> <span class="caption-title">Evaluation of rupintrivir, a PV 3C protease inhibitor.</span><p id="p-15" class="first-child">(<strong>a</strong>) Dose-response analysis. Percentage of single, infected (green) cells was determined as a function of rupintrivir concentration. (<strong>b</strong>-<strong>f</strong>) Distributions for each parameter in the presence of 10 or 20 nM rupintrivir were compared to that in the absence of drug using a t-test. A single asterisk indicates a p-value less than 0.05; two asterisks indicate a p-value is less than 0.005. Numerical values for experimental parameters are provided in <strong>Table S3</strong> and statistical analysis in <strong>Table S4</strong>. The parameters presented in the panels are as follows: (<strong>b</strong>) maximum; (<strong>c</strong>) slope; (<strong>d</strong>) infection time; (<strong>e</strong>) start point; (<strong>f</strong>) midpoint.</p><div class="sb-div caption-clear"></div></div></div></div><div id="sec-6" class="subsection"><h3>Evaluation of HSP90 inhibitors</h3><p id="p-16">Compounds antagonizing the function of cellular chaperones represent an emergent class of anti-cancer and antiviral therapeutics (<a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">Chatterjee and Burns, 2017</a>; <a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">Geller et al., 2012</a>). Chaperones of the heat-shock-protein-90 (HSP90) family are required when the cell is growing fast and/or producing high levels of proteins, as observed in cancer cells or in virus-infected cells. Seminal studies from the Frydman and Andino laboratories demonstrate a clear, essential role for HSP90 in production of infectious PV virions. However, every step of the virus lifecycle has been suggested as a target for HSP90 when viruses outside of the picornavirus family are considered (<a id="xref-ref-18-2" class="xref-bibr" href="#ref-18">Geller et al., 2012</a>; <a id="xref-ref-35-1" class="xref-bibr" href="#ref-35">Wang et al., 2017</a>). The benefit of targeting antiviral therapeutics to cellular proteins is that the likelihood for evolution of resistance is minimized (<a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">Geller et al., 2007</a>).</p><p id="p-17">We have used geldanamycin (GA), because it is a potent inhibitor of HSP90 (nM range) that is active against PV (<a id="xref-ref-19-2" class="xref-bibr" href="#ref-19">Geller et al., 2007</a>). The presence of GA reduced the number of infections established by 22 ± 4% with an IC50 value of 30 ± 8 nM (<strong><a id="xref-fig-3-1" class="xref-fig" href="#F3">Fig. 3a</a></strong>). An earlier study did not observe an impact of GA prior to virus assembly; however, it is possible that a reduction of the magnitude shown here would be concealed by experimental error (<a id="xref-ref-19-3" class="xref-bibr" href="#ref-19">Geller et al., 2007</a>). Because infection is monitored by eGFP, which requires virus entry, genome replication, and genome translation, interference with any of these steps would lead to a reduction in the number of eGFP-positive cells. It is clear, however, that translation and folding of eGFP are not altered in the presence of the highest concentration of GA used in this experiment (<strong>Fig. S5</strong>).</p><div id="F3" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F3.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Evaluation of geldanamycin (GA), an HSP90 inhibitor. (a) Dose-response analysis. Percentage of single, infected (green) cells was determined as a function of GA concentration. (b- f) Distributions for each parameter in the presence of 25 or 100 nM GA were compared to that in the absence of drug using a t-test. A single asterisk indicates a p-value less than 0.05; two asterisks indicate a p-value less than 0.005. Numerical values for experimental parameters are provided in Table S5 and statistical analysis in Table S6. The parameters presented in the panels are as follows: (b) maximum; (c) slope; (d) infection time; (e) start point; (f) midpoint." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-353495974" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;&lt;span class=&quot;caption-title&quot;&gt;Evaluation of geldanamycin (GA), an HSP90 inhibitor.&lt;/span&gt; (&lt;strong&gt;a&lt;/strong&gt;) Dose-response analysis. Percentage of single, infected (green) cells was determined as a function of GA concentration. (&lt;strong&gt;b&lt;/strong&gt;- &lt;strong&gt;f&lt;/strong&gt;) Distributions for each parameter in the presence of 25 or 100 nM GA were compared to that in the absence of drug using a t-test. A single asterisk indicates a p-value less than 0.05; two asterisks indicate a p-value less than 0.005. Numerical values for experimental parameters are provided in &lt;strong&gt;Table S5&lt;/strong&gt; and statistical analysis in &lt;strong&gt;Table S6&lt;/strong&gt;. The parameters presented in the panels are as follows: (&lt;strong&gt;b&lt;/strong&gt;) maximum; (&lt;strong&gt;c&lt;/strong&gt;) slope; (&lt;strong&gt;d&lt;/strong&gt;) infection time; (&lt;strong&gt;e&lt;/strong&gt;) start point; (&lt;strong&gt;f&lt;/strong&gt;) midpoint.&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 3." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F3.medium.gif" width="370" height="440"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 3." src="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F3.medium.gif" width="370" height="440"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F3.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 3." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F3.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">Figure 3.</span> <span class="caption-title">Evaluation of geldanamycin (GA), an HSP90 inhibitor.</span><p id="p-18" class="first-child">(<strong>a</strong>) Dose-response analysis. Percentage of single, infected (green) cells was determined as a function of GA concentration. (<strong>b</strong>- <strong>f</strong>) Distributions for each parameter in the presence of 25 or 100 nM GA were compared to that in the absence of drug using a t-test. A single asterisk indicates a p-value less than 0.05; two asterisks indicate a p-value less than 0.005. Numerical values for experimental parameters are provided in <strong>Table S5</strong> and statistical analysis in <strong>Table S6</strong>. The parameters presented in the panels are as follows: (<strong>b</strong>) maximum; (<strong>c</strong>) slope; (<strong>d</strong>) infection time; (<strong>e</strong>) start point; (<strong>f</strong>) midpoint.</p><div class="sb-div caption-clear"></div></div></div><p id="p-19">Analysis of the single-cell data is presented in <strong>Tables S5</strong> and <strong>S6</strong>. The mean of the distribution of values for the maximum parameter did not change in the presence of GA (<strong><a id="xref-fig-3-2" class="xref-fig" href="#F3">Fig. 3b</a></strong>), in contrast to the inhibitors targeting viral proteins. Observation of a statistically significant difference in the distribution of the values for the infection-time parameter was concentration dependent (<strong><a id="xref-fig-3-3" class="xref-fig" href="#F3">Fig. 3d</a></strong>). A statistically significant difference for mean of the distributions for the remaining parameters was observed at concentrations corresponding to the IC50 and above (<strong><a id="xref-fig-3-4" class="xref-fig" href="#F3">Figs. 3c, 3e</a></strong> and <strong><a id="xref-fig-3-5" class="xref-fig" href="#F3">3f</a></strong>). A third signature of antiviral action is therefore revealed with GA.</p><p id="p-20">Given the interest in using HSP90 inhibitors as therapeutics for cancer, a variety of compounds exist (<a id="xref-ref-23-1" class="xref-bibr" href="#ref-23">Hwang et al., 2009</a>; <a id="xref-ref-31-1" class="xref-bibr" href="#ref-31">Sidera and Patsavoudi, 2014</a>). For example, ganetespib (GS) is an HSP90 inhibitor that differs from GA substantially in chemical structure (compare inset in <strong>Fig. S6</strong> to that in <strong><a id="xref-fig-3-6" class="xref-fig" href="#F3">Fig. 3a</a></strong>), has a higher affinity for HSP90 than GA (<a id="xref-ref-27-1" class="xref-bibr" href="#ref-27">Prince et al., 2015</a>), but is thought to have the same mechanism of action (<a id="xref-ref-29-1" class="xref-bibr" href="#ref-29">Roe et al., 1999</a>; <a id="xref-ref-38-1" class="xref-bibr" href="#ref-38">Ying et al., 2012</a>). Use of GS provides an important test of the capacity of the single-cell analysis to reveal common signature for compounds with common mechanisms.</p><p id="p-21">In contrast to observations with GA, GS reduced the number of infections established by 70 ± 14% with an IC50 of 3 ± 1 nM. Analysis of the single-cell data is presented in <strong>Tables S7</strong> and <strong>S8</strong>. The impact of GS on the five phenomenological parameters were the same as observed for GA (<strong>Fig. S6</strong>). In this case, it is clear that mechanistically identical compounds yield identical signatures at the single-cell level.</p></div><div id="sec-7" class="subsection"><h3>Evaluation of antiviral drug combinations</h3><p id="p-22">The long-term utility of an antiviral therapy is determined, in part, by the time required for resistance mutants to emerge. One approach to delaying or even eliminating the emergence of drug-resistant mutants is the use of antiviral combinations (<a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">Dunning et al., 2014</a>; <a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">Hofmann et al., 2009</a>). What is often evaluated is the ability of two drugs to exhibit greater efficacy (synergy) in preventing infection in combination than observed when either drug is used alone. We evaluated the ability of 2’-<em>C</em>-Me-A to synergize with GA by treating cells with the concentrations of one or both at their IC50 values (<strong><a id="xref-fig-4-1" class="xref-fig" href="#F4">Fig. 4a</a></strong>). In the absence of drug, 34 ± 3% of cells in the device were infected. That number was reduced to 18 ± 2%, 30 ± 3%, or 15 ± 3% in the presence of 2’-<em>C</em>-Me-A, GA, or the combination thereof, respectively. Based on this observation alone, the conclusion would be that this combination of antiviral agents is not even additive. Analysis of the entire single-cell dataset is presented in <strong>Tables S9</strong> and <strong>S10</strong>. Because 2’-<em>C</em>-Me-A exhibits the most substantial antiviral effect relative to the DMS0 control, here we compare the combination to 2’-<em>C</em>-Me-A alone. We observed a statistically significant difference for all parameters (<strong><a id="xref-fig-4-2" class="xref-fig" href="#F4">Figs. 4b - 4f</a></strong>). Single-cell analysis therefore has the ability to reveal efficacy of drug combinations masked at the population level. We performed the comparable experiment with GS and reached the same conclusion (<strong>Fig. S7, Tables S10</strong> and <strong>S11</strong>).</p><div id="F4" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F4.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Evaluation of an antiviral drug combination: 2&#x2019;-C-Me-A and GA. (a) Combination of 2&#x2019;-C-Me-A and GA is not synergistic based on the fraction of established infections. Percentage of single, infected (green) cells was determined in the presence of 50 &#xB5;M 2&#x2019;-C-Me-A, 25 nM GA, or the combination of the two drugs. (b-f) Distributions for each parameter in the presence of the combination were compared to that in the presence of GA alone using a t-test. Numerical values for experimental parameters are provided in Table S9 and statistical analysis in Table S10. The parameters presented in the panels are as follows: (b) maximum; (c) slope; (d) infection time; (e) start point; (f) midpoint." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-353495974" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;&lt;span class=&quot;caption-title&quot;&gt;Evaluation of an antiviral drug combination: 2&#x2019;-&lt;em&gt;C&lt;/em&gt;-Me-A and GA.&lt;/span&gt; (&lt;strong&gt;a&lt;/strong&gt;) Combination of 2&#x2019;-&lt;em&gt;C&lt;/em&gt;-Me-A and GA is not synergistic based on the fraction of established infections. Percentage of single, infected (green) cells was determined in the presence of 50 &#xB5;M 2&#x2019;-&lt;em&gt;C&lt;/em&gt;-Me-A, 25 nM GA, or the combination of the two drugs. (&lt;strong&gt;b&lt;/strong&gt;-&lt;strong&gt;f&lt;/strong&gt;) Distributions for each parameter in the presence of the combination were compared to that in the presence of GA alone using a t-test. Numerical values for experimental parameters are provided in &lt;strong&gt;Table S9&lt;/strong&gt; and statistical analysis in &lt;strong&gt;Table S10&lt;/strong&gt;. The parameters presented in the panels are as follows: (&lt;strong&gt;b&lt;/strong&gt;) maximum; (&lt;strong&gt;c&lt;/strong&gt;) slope; (&lt;strong&gt;d&lt;/strong&gt;) infection time; (&lt;strong&gt;e&lt;/strong&gt;) start point; (&lt;strong&gt;f&lt;/strong&gt;) midpoint.&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 4." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F4.medium.gif" width="374" height="440"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 4." src="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F4.medium.gif" width="374" height="440"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F4.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 4." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F4.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">Figure 4.</span> <span class="caption-title">Evaluation of an antiviral drug combination: 2’-<em>C</em>-Me-A and GA.</span><p id="p-23" class="first-child">(<strong>a</strong>) Combination of 2’-<em>C</em>-Me-A and GA is not synergistic based on the fraction of established infections. Percentage of single, infected (green) cells was determined in the presence of 50 µM 2’-<em>C</em>-Me-A, 25 nM GA, or the combination of the two drugs. (<strong>b</strong>-<strong>f</strong>) Distributions for each parameter in the presence of the combination were compared to that in the presence of GA alone using a t-test. Numerical values for experimental parameters are provided in <strong>Table S9</strong> and statistical analysis in <strong>Table S10</strong>. The parameters presented in the panels are as follows: (<strong>b</strong>) maximum; (<strong>c</strong>) slope; (<strong>d</strong>) infection time; (<strong>e</strong>) start point; (<strong>f</strong>) midpoint.</p><div class="sb-div caption-clear"></div></div></div></div><div id="sec-8" class="subsection"><h3>Evaluation of single-cell data by using principal component analysis (PCA)</h3><p id="p-24">Our evaluation of three classes of anti-PV drugs revealed three unique signatures based on changes to the phenomenological parameters used to describe infection dynamics. We reasoned that PCA might provide an even more robust approach to compare datasets using our five parameters. As shown in <strong><a id="xref-fig-5-1" class="xref-fig" href="#F5">Fig. 5</a></strong>, PCA resolves each class of inhibitor from the other, as well as from outcomes in the absence of drug. Importantly, the mechanistically related but chemically distinct inhibitors of HSP90 cluster by PCA (see GA and GS in <strong><a id="xref-fig-5-2" class="xref-fig" href="#F5">Fig. 5</a></strong>). We conclude that single-cell analysis of antiviral therapeutics can provide not only information on the efficacy of a drug but also information on the mechanism of action. This experimental paradigm should have a transformative impact on the drug-development process.</p><div id="F5" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F5.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Mechanistic classes of antiviral agents distinguished by principal component analysis (PCA) of single-cell data. Points representing groups of single cells are colored according to compound identities with each point representing a different drug-treatment concentration. PCA was performed using the mean values of the maximum, slope, infection time, start point and midpoint from the various drug-treatment concentrations and control groups. The top two principal components accounted for 94% of the total variance. The light blue lines indicate the relationship between variables in the space of the first two components." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-353495974" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;span xmlns=&quot;http://www.w3.org/1999/xhtml&quot; class=&quot;caption-title&quot;&gt;Mechanistic classes of antiviral agents distinguished by principal component analysis (PCA) of single-cell data.&lt;/span&gt; Points representing groups of single cells are colored according to compound identities with each point representing a different drug-treatment concentration. PCA was performed using the mean values of the maximum, slope, infection time, start point and midpoint from the various drug-treatment concentrations and control groups. The top two principal components accounted for 94% of the total variance. The light blue lines indicate the relationship between variables in the space of the first two components.&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 5." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F5.medium.gif" width="440" height="388"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 5." src="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F5.medium.gif" width="440" height="388"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F5.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 5." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F5.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">Figure 5.</span> <span class="caption-title">Mechanistic classes of antiviral agents distinguished by principal component analysis (PCA) of single-cell data.</span><p id="p-25" class="first-child">Points representing groups of single cells are colored according to compound identities with each point representing a different drug-treatment concentration. PCA was performed using the mean values of the maximum, slope, infection time, start point and midpoint from the various drug-treatment concentrations and control groups. The top two principal components accounted for 94% of the total variance. The light blue lines indicate the relationship between variables in the space of the first two components.</p><div class="sb-div caption-clear"></div></div></div></div></div><div class="section" id="sec-9"><h2 class="">DISCUSSION</h2><p id="p-26">The era of single-cell virology has begun (<a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">Combe et al., 2015</a>; <a id="xref-ref-20-6" class="xref-bibr" href="#ref-20">Guo et al., 2017</a>; <a id="xref-ref-30-1" class="xref-bibr" href="#ref-30">Russell et al., 2018</a>). Infection outcomes in cells are determined, in part, by stochastic processes (<a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">Heldt et al., 2015</a>). For example, the presence and abundance of viral-restriction factors and viral-replication-promoting factors of the host are largely governed by stochastic gene expression (<a id="xref-ref-28-1" class="xref-bibr" href="#ref-28">Raj and van Oudenaarden, 2008</a>). As a result, substantial between-cell variation exists in all quantifiable parameters of infection. An underappreciated consequence of the behavior of systems such as these is the non-self-averaging nature of these systems, which means that the population average of any single-cell parameter will almost certainly fail to represent the dynamics within any single cell (<a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">Derrida, 1997</a>; <a id="xref-ref-36-1" class="xref-bibr" href="#ref-36">Wiseman and Domany, 1998</a>). The practical complication arising from this phenomenon is that changes in the average kinetics observed in a growth curve for a virus caused by a perturbation, for example exposure to an antiviral therapeutic, will not inform accurately the step(s) of the viral lifecycle impacted most by the perturbation.</p><p id="p-27">With this perspective in mind, it is not surprising that our previous evaluation of an antiviral ribonucleotide using a single-cell approach revealed the unexpected finding that the most-fit members of the viral population were most susceptible to this class of compounds (<a id="xref-ref-20-7" class="xref-bibr" href="#ref-20">Guo et al., 2017</a>). This observation left one major unresolved question: do all effective antiviral therapeutics target the same subpopulation of viruses or do unique signatures exist for distinct mechanistic classes of antiviral therapeutics? Addressing these questions is the central objective of this study.</p><p id="p-28">Our first-generation microfluidic device for on-chip investigation of viral infection dynamics relied on cell density as the mechanism to achieve isolation of single cells in wells of the device, an approach which leaves most wells of the device empty (<a id="xref-ref-20-8" class="xref-bibr" href="#ref-20">Guo et al., 2017</a>). We have redesigned the device to add physical cell-trapping structures to each well. The outcome of which is the ability to achieve single-cell occupancy of ~90% of the ~6000 wells of the device (<strong><a id="xref-fig-1-6" class="xref-fig" href="#F1">Figs. 1</a>, S1</strong>-<strong>S3</strong>). The enhanced occupancy enabled the complete characterization of antiviral therapeutics by permitting the acquisition of complete dose-response curves (e.g. <strong><a id="xref-fig-2-7" class="xref-fig" href="#F2">Fig. 2a</a></strong>).</p><p id="p-29">The three classes of antiviral therapeutics chosen target a viral polymerase (2’-C-methyladenosine, 2’-<em>C</em>-Me-A, <strong>Fig. S4</strong>), a viral protease (rupintrivir, <strong><a id="xref-fig-2-8" class="xref-fig" href="#F2">Fig. 2</a></strong>), or a host factor, HSP90, (geldanamycin, GA, <strong><a id="xref-fig-3-7" class="xref-fig" href="#F3">Fig. 3</a></strong>; ganetespib, GS, <strong>Fig. S6</strong>). Our data-analysis pipeline emphasizes five phenomenological parameters with correlates to traditional parameters for assessment of the viral lifecycle.<sup>7</sup> The major finding of this study is that each class of antiviral therapeutics exhibited a unique signature with respect to the five phenomenological parameters measured and so much so that it was possible to use principal component analysis (PCA) to stratify the different therapeutic classes (<strong><a id="xref-fig-5-3" class="xref-fig" href="#F5">Fig. 5</a></strong>). Importantly, both GA and GS overlapped by PCA despite their substantial differences in structure and efficacy (<strong><a id="xref-fig-5-4" class="xref-fig" href="#F5">Fig. 5</a></strong>).</p><p id="p-30">To our knowledge, this study represents the first analysis of a range of antiviral therapeutics on viral infection dynamics at the single-cell level. The resolution afforded by this approach is unprecedented when compared to other cell-based approaches, which only provide a measure of efficacy. Given the substantial effort required to go from compound to mechanism using the traditional experimental paradigm, the ability of single-cell analysis to inform mechanism should make this approach a welcome addition to the drug discovery and development toolbox. It is not uncommon for analogues to be synthesized during the drug-development process that lose specificity or even function by a different mechanism of action, single-cell analysis has the potential to reveal changes such as these at the start of the analysis instead of much, much later in the development process. Finally, although we have used antiviral agents to demonstrate the power of single-cell analysis, use of this technology and approach will be applicable to the discovery and development of any class of therapeutics that can be assessed in cell culture.</p></div><div class="section" id="sec-10"><h2 class="">METHODS</h2><div id="sec-11" class="subsection"><h3>Cells</h3><p id="p-31">HeLa and HeLa S3 cells were obtained from American Type Culture Collection (ATCC) and maintained in DMEM/F12 (1:1) (Life Technologies) supplemented with 10% fetal bovine serum (FBS, Atlanta Biologicals) and 100 IU/mL penicillin–streptomycin (Corning), in a humidified atmosphere of 95% air and 5% CO<sub>2</sub> at 37 °C.</p></div><div id="sec-12" class="subsection"><h3>Viruses</h3><p id="p-32">To generate EGFP-tagged poliovirus used in this work, pMo-EGFP-PV-WT plasmid was linearized with ApaI and purified with QIAEX II Gel Extraction Kit (Qiagen, Netherlands). With the linearized plasmid as the template, viral RNA was transcribed at 37°C for 5.5 hours in a 20-μL reaction medium containing 350 mM HEPES pH 7.5, 32 mM magnesium acetate, 40 mM dithiothreitol (DTT), 2 mM spermidine, 28 mM nucleoside triphosphates (NTPs), 0.025 µg/µL linearized DNA, and 0.025 µg/µL T7 RNA polymerase. After removing magnesium pyrophosphate in the mixture by centrifugation for 2 minutes, RNA concentration was measured by scanning the gel at fluorescence mode with a Typhoon 8600 scanner (Promega, USA). Then, 5 µg of viral RNA were utilized to transfect HeLa cells cultured at 37°C by electroporation. Virus was harvested by three repeated freeze-thaw cycles, centrifuged at 3000 rpm for 5 minutes, and suspended in 0.5% nonidet P-40 (NP-40). For purification, the supernatant was mixed with 1 volume of 20% PEG-8000/1 M NaCl solution and incubated overnight at 4°C. After centrifugation at 8000 × g for 10 minutes at 4°C, the pellet was resuspended in PBS and filtered with Centricon® Plus-70 (EMD Millipore, USA). Plaque assay was performed to determine the virus titer.</p></div><div id="sec-13" class="subsection"><h3>Microfluidic devices</h3><p id="p-33">The microfluidic layers were fabricated from polydimethylsiloxane (PDMS, GE RTV615) by standard soft lithography techniques. The molds were fabricated by coating photoresist SU-8 25/50 with desired thicknesses on a silicon wafer and photolithographic patterning (Figure S1 and S2). Premixed PDMS prepolymer and curing agent (ratio 5/1) were poured onto the mold for valve layer and cured. Premixed PDMS prepolymer and curing agent (ratio 20/1) were spin-coated on the mold for channel layer at 1500 rpm for 1 minute and incubated at 65 °C for 20 min. Then the valve layer was released from the mold and placed on the channel layer with alignment. The assembly was baked at 65 °C overnight for efficient bonding. The assembly was further bonded with alignment to the microwells layer cured from premixed PDMS prepolymer and curing agent (ratio 20/1) by baking at 65 °C overnight. The obtained device was further bonded to a glass slide to prevent deformation when applying a pressure to the valves.</p></div><div id="sec-14" class="subsection"><h3>On-chip experiments</h3><p id="p-34">Dimethyl sulfoxide (DMSO) and rupintrivir were purchased from Sigma Chemical Co. (St. Louis, MO, USA). 2’-<em>C</em>-methyladenosine (2’-<em>C</em>-Me-A) was obtained from Carbosynth Limited (Compton, Berkshire, UK). Solutions of geldanamycin and ganetespib in DMSO were kindly provided by Dr. Xin Zhang (Department of Chemistry, The Pennsylvania State University) and Dr. Judith Frydman (Department of Biology, Stanford University), respectively. All the antiviral compounds were pre-diluted in DMSO for use. For no drug groups, same volumes of DMSO were spiked into the culture medium.</p><p id="p-35">For each group, 2 × 10<sup>5</sup> HeLa S3 cells were cultured with drug-containing medium for 1 h. Then the cells were centrifuged, resuspended in PBS, and mixed with EGFP-PV at the MOI of 0.5 PFU/cell. After shaking at 140 rpm for 30 min, the cells were centrifugated and resuspended in mediums with corresponding treatments. With a PHD Ultra syringe pump (Harvard Apparatus), the cell suspensions were infused to the inlets of a microfluidic device for trapping of single-cells for 5 min. Afterwards, a pressure of 30 psi was applied to the valves to isolate the microwells.</p><p id="p-36">The device was placed in the chamber of a stage top WSKM GM2000 incubation system (Tokai, Japan) adapted to a Nikon Eclipse Ti inverted microscope (Nikon, Japan) equipped with a ProScan II motorized flat top stage (Prior Scientific, USA). With this setup, bright-field and fluorescence images of the microwells were automatically acquired every 30 minutes from 2.5 hpi to 24 hpi. In each image, 36 (6 × 6) microwells were included with a CFI60 Plan Apochromat Lambda 10× objective and a Hamamatsu C11440 camera.</p></div><div id="sec-15" class="subsection"><h3>Data processing</h3><p id="p-37">A customized MATLAB script was employed to extract the fluorescence intensity and background intensity for each microwell in each fluorescent image. (Fluorescence intensity - Background)/Background was calculated to represent the relative intensity. Meanwhile, wells containing two or more infected cells and showing auto-fluorescence or out-of-focus signals were manually excluded. As a result, the fluorescence intensity of each infected single-cell over time could be obtained. With a customized package of R, the maximum, slope, infection time, start point and midpoint were derived (<a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">Caglar et al., 2018</a>). For comparison of different experiments, the intensities were further normalized to uniformize the mean values of the maximums for the no drug groups (2.00 a.u. in this work). The distributions of cell densities were plotted with the area under each curve representing the relative number of infected cells (given 100 cells for no drug group).</p></div></div><div class="section" id="sec-18"><h2 class="">Author Contributions</h2><p id="p-40">W.L. and C.E.C. designed the experiments. W.L. conducted the experiments. A.W and J.J.A. contributed unique reagents. W.L., M.U.C., and Z.M. performed image and data analysis. W.L., M.U.C., A.W., J.J.A., C.O.W., and C.E.C analyzed the data. W.L. and C.E.C wrote the manuscript.</p></div><div class="section" id="sec-19"><h2 class="">Declaration of Interests</h2><p id="p-41">The authors declare no competing financial interest.</p></div><div class="section display-objects" id="sec-20"><h2 class="">Graphical Abstract</h2><div id="F6" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F6.large.jpg?width=800&amp;height=600&amp;carousel=1" title="" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-353495974" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure6" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F6.medium.gif" width="440" height="440"/><noscript><img class="highwire-fragment fragment-image" alt="Figure6" src="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F6.medium.gif" width="440" height="440"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F6.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure6" data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2019/04/12/606715/F6.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div></div></div><div class="section ack" id="ack-1"><h2 class="">Acknowledgements</h2><p id="p-39">This work was supported by grant AI12056 from NIAID, NIH to C.O.W. and C.E.C.. A.W. is the recipient of a postdoctoral fellowship from the American Heart Association. W.L. thanks Dr. Sixing Li, Dr. Peng Li, Dr. Po-Hsun Huang and Liqiang Ren for helpful discussions. C.E.C. thanks the following: Dr. Susanna Manrubia for sharing her thoughts on non-self-averaging systems; Dr. Judith Frydman and Dr. Raul Andino for encouraging us to evaluate inhibitors of HSP90.</p></div><div class="section ref-list" id="ref-list-1"><h2 class="">References</h2><ol class="cit-list ref-use-labels"><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference  in text" id="ref-1">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.1" data-doi="10.1016/j.virol.2015.03.022"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Andino</span>,  <span class="cit-name-given-names">R.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Domingo</span>,  <span class="cit-name-given-names">E.</span></span> (<span class="cit-pub-date">2015</span>). <span class="cit-article-title">Viral quasispecies</span>. <abbr class="cit-jnl-abbrev">Virology</abbr> <span class="cit-vol">479</span>, <span class="cit-fpage">46</span>–<span class="cit-lpage">51</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DVirology%26rft.volume%253D479%26rft.spage%253D46%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.virol.2015.03.022%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.virol.2015.03.022&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference  in text" id="ref-2">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.2"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Antona</span>,  <span class="cit-name-given-names">D.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kossorotoff</span>,  <span class="cit-name-given-names">M.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Schuffenecker</span>,  <span class="cit-name-given-names">I.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Mirand</span>,  <span class="cit-name-given-names">A.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Leruez-Ville</span>,  <span class="cit-name-given-names">M.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Bassi</span>,  <span class="cit-name-given-names">C.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Aubart</span>,  <span class="cit-name-given-names">M.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Moulin</span>,  <span class="cit-name-given-names">F.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Lévy-Bruhl</span>,  <span class="cit-name-given-names">D.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Henquell</span>,  <span class="cit-name-given-names">C.</span></span>, <span class="cit-etal">et al.</span> (<span class="cit-pub-date">2016</span>). <span class="cit-article-title">Severe paediatric conditions linked with EV-A71 and EV-D68, France, May to October 2016</span>. <abbr class="cit-jnl-abbrev">Eurosurveillance</abbr> <span class="cit-vol">21</span>, <span class="cit-fpage">11</span>–<span class="cit-lpage">14</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DEurosurveillance%26rft.volume%253D21%26rft.spage%253D11%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference  in text" id="ref-3">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.3" data-doi="10.1056/NEJMoa1404505"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Baize</span>,  <span class="cit-name-given-names">S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Pannetier</span>,  <span class="cit-name-given-names">D.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Oestereich</span>,  <span class="cit-name-given-names">L.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Rieger</span>,  <span class="cit-name-given-names">T.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Koivogui</span>,  <span class="cit-name-given-names">L.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Magassouba</span>,  <span class="cit-name-given-names">N.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Soropogui</span>,  <span class="cit-name-given-names">B.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Sow</span>,  <span class="cit-name-given-names">M. S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Keïta</span>,  <span class="cit-name-given-names">S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">De Clerck</span>,  <span class="cit-name-given-names">H.</span></span>, <span class="cit-etal">et al.</span> (<span class="cit-pub-date">2014</span>). <span class="cit-article-title">Emergence of Zaire Ebola virus disease in Guinea</span>. <abbr class="cit-jnl-abbrev">N. Engl. J. Med</abbr>. <span class="cit-vol">371</span>, <span class="cit-fpage">1418</span>–<span class="cit-lpage">1425</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DN.%2BEngl.%2BJ.%2BMed%26rft.volume%253D371%26rft.spage%253D1418%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa1404505%26rft_id%253Dinfo%253Apmid%252F24738640%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1056/NEJMoa1404505&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=24738640&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2019%2F04%2F12%2F606715.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000342674800010&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference  in text" id="ref-4">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.4" data-doi="10.1128/AAC.49.2.619-626.2005"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Binford</span>,  <span class="cit-name-given-names">S. L.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Maldonado</span>,  <span class="cit-name-given-names">F.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Brothers</span>,  <span class="cit-name-given-names">M. A.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Weady</span>,  <span class="cit-name-given-names">P. T.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Zalman</span>,  <span class="cit-name-given-names">L. S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Meador</span>,  <span class="cit-name-given-names">J. W.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Matthews</span>,  <span class="cit-name-given-names">D. A.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Patick</span>,  <span class="cit-name-given-names">A. K.</span></span> (<span class="cit-pub-date">2005</span>). <span class="cit-article-title">Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor</span>. <abbr class="cit-jnl-abbrev">Antimicrob. Agents Chemother</abbr>. <span class="cit-vol">49</span>, <span class="cit-fpage">619</span>–<span class="cit-lpage">626</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253DBinford%26rft.auinit1%253DS.%2BL.%26rft.volume%253D49%26rft.issue%253D2%26rft.spage%253D619%26rft.epage%253D626%26rft.atitle%253DConservation%2Bof%2BAmino%2BAcids%2Bin%2BHuman%2BRhinovirus%2B3C%2BProtease%2BCorrelates%2Bwith%2BBroad-Spectrum%2BAntiviral%2BActivity%2Bof%2BRupintrivir%252C%2Ba%2BNovel%2BHuman%2BRhinovirus%2B3C%2BProtease%2BInhibitor%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.49.2.619-626.2005%26rft_id%253Dinfo%253Apmid%252F15673742%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjg6IjQ5LzIvNjE5IjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTkvMDQvMTIvNjA2NzE1LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference  in text" id="ref-5">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.5" data-doi="10.1016/S0140-6736(11)60281-X"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Burt</span>,  <span class="cit-name-given-names">F. J.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Rolph</span>,  <span class="cit-name-given-names">M. S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Rulli</span>,  <span class="cit-name-given-names">N. E.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Mahalingam</span>,  <span class="cit-name-given-names">S.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Heise</span>,  <span class="cit-name-given-names">M. T.</span></span> (<span class="cit-pub-date">2012</span>) <span class="cit-article-title">Chikungunya: a re-emerging virus</span>. <abbr class="cit-jnl-abbrev">Lancet</abbr> <span class="cit-vol">379</span>, <span class="cit-fpage">662</span>–<span class="cit-lpage">671</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DBurt%26rft.auinit1%253DF.%2BJ.%26rft.volume%253D379%26rft.issue%253D9816%26rft.spage%253D662%26rft.epage%253D671%26rft.atitle%253DChikungunya%253A%2Ba%2Bre-emerging%2Bvirus.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252811%252960281-X%26rft_id%253Dinfo%253Apmid%252F22100854%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/S0140-6736(11)60281-X&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=22100854&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2019%2F04%2F12%2F606715.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000300629000037&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference  in text" id="ref-6">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.6"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Caglar</span>,  <span class="cit-name-given-names">M. U.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Teufel</span>,  <span class="cit-name-given-names">A. I.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Wilke</span>,  <span class="cit-name-given-names">C. O.</span></span> (<span class="cit-pub-date">2018</span>). <span class="cit-article-title">Sicegar: R package for sigmoidal and double-sigmoidal curve fitting</span>. <abbr class="cit-jnl-abbrev">PeerJ</abbr> <span class="cit-vol">6</span>, <span class="cit-fpage">e4251</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DPeerJ%26rft.volume%253D6%26rft.spage%253De4251%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference  in text" id="ref-7">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.7" data-doi="10.1016/S1473-3099(02)00368-7"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Campbell</span>,  <span class="cit-name-given-names">G. L.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Marfin</span>,  <span class="cit-name-given-names">A. A.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Lanciotti</span>,  <span class="cit-name-given-names">R. S.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Gubler</span>,  <span class="cit-name-given-names">D. J.</span></span> (<span class="cit-pub-date">2002</span>). <span class="cit-article-title">West Nile virus</span>. <abbr class="cit-jnl-abbrev">Lancet Infect. Dis</abbr>. <span class="cit-vol">2</span>, <span class="cit-fpage">519</span>–<span class="cit-lpage">529</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DThe%2BLancet%2Binfectious%2Bdiseases%26rft.stitle%253DLancet%2BInfect%2BDis%26rft.aulast%253DCampbell%26rft.auinit1%253DG.%2BL.%26rft.volume%253D2%26rft.issue%253D9%26rft.spage%253D519%26rft.epage%253D529%26rft.atitle%253DWest%2BNile%2Bvirus.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS1473-3099%252802%252900368-7%26rft_id%253Dinfo%253Apmid%252F12206968%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/S1473-3099(02)00368-7&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=12206968&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2019%2F04%2F12%2F606715.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000177759100017&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference  in text" id="ref-8">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.8"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Campos</span>,  <span class="cit-name-given-names">G. S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Bandeira</span>,  <span class="cit-name-given-names">A. C.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Sardi</span>,  <span class="cit-name-given-names">S. I.</span></span> (<span class="cit-pub-date">2015</span>). <span class="cit-article-title">Zika virus outbreak, Bahia, Brazil. Emerg</span>. <abbr class="cit-jnl-abbrev">Infect. Dis</abbr>. <span class="cit-vol">21</span>, <span class="cit-fpage">1885</span>–<span class="cit-lpage">1886</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DInfect.%2BDis%26rft.volume%253D21%26rft.spage%253D1885%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference  in text" id="ref-9">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.9" data-doi="10.1074/jbc.M210914200"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Carroll</span>,  <span class="cit-name-given-names">S. S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Tomassini</span>,  <span class="cit-name-given-names">J. E.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Bosserman</span>,  <span class="cit-name-given-names">M.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Getty</span>,  <span class="cit-name-given-names">K.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Stahlhut</span>,  <span class="cit-name-given-names">M. W.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Eldrup</span>,  <span class="cit-name-given-names">A. B.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Bhat</span>,  <span class="cit-name-given-names">B.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Hall</span>,  <span class="cit-name-given-names">D.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Simcoe</span>,  <span class="cit-name-given-names">A. L.</span></span>, <span class="cit-auth"><span class="cit-name-surname">LaFemina</span>,  <span class="cit-name-given-names">R.</span></span>, <span class="cit-etal">et al.</span> (<span class="cit-pub-date">2003</span>). <span class="cit-article-title">Inhibition of hepatitis C virus RNA replication by 2’-modified nucleoside analogs</span>. <abbr class="cit-jnl-abbrev">J. Biol. Chem</abbr>. <span class="cit-vol">278</span>, <span class="cit-fpage">11979</span>–<span class="cit-lpage">11984</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BBiol.%2BChem%26rft_id%253Dinfo%253Adoi%252F10.1074%252Fjbc.M210914200%26rft_id%253Dinfo%253Apmid%252F12554735%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiamJjIjtzOjU6InJlc2lkIjtzOjEyOiIyNzgvMTQvMTE5NzkiO3M6NDoiYXRvbSI7czozNzoiL2Jpb3J4aXYvZWFybHkvMjAxOS8wNC8xMi82MDY3MTUuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference  in text" id="ref-10">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.10" data-doi="10.3390/ijms18091978"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Chatterjee</span>,  <span class="cit-name-given-names">S.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Burns</span>,  <span class="cit-name-given-names">T. F.</span></span> (<span class="cit-pub-date">2017</span>). <span class="cit-article-title">Targeting heat shock proteins in cancer: a promising therapeutic approach</span>. <abbr class="cit-jnl-abbrev">Int. J. Mol. Sci</abbr>. <span class="cit-vol">18</span>, <span class="cit-fpage">1978</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DInt.%2BJ.%2BMol.%2BSci%26rft.volume%253D18%26rft.spage%253D1978%26rft_id%253Dinfo%253Adoi%252F10.3390%252Fijms18091978%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.3390/ijms18091978&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference  in text" id="ref-11">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.11" data-doi="10.1016/j.antiviral.2009.09.014"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Cihlar</span>,  <span class="cit-name-given-names">T.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Ray</span>,  <span class="cit-name-given-names">A. S.</span></span> (<span class="cit-pub-date">2010</span>). <span class="cit-article-title">Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine</span>. <abbr class="cit-jnl-abbrev">Antiviral Res</abbr>. <span class="cit-vol">85</span>, <span class="cit-fpage">39</span>–<span class="cit-lpage">58</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntiviral%2Bresearch%26rft.stitle%253DAntiviral%2BRes%26rft.aulast%253DCihlar%26rft.auinit1%253DT.%26rft.volume%253D85%26rft.issue%253D1%26rft.spage%253D39%26rft.epage%253D58%26rft.atitle%253DNucleoside%2Band%2Bnucleotide%2BHIV%2Breverse%2Btranscriptase%2Binhibitors%253A%2B25%2Byears%2Bafter%2Bzidovudine.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.antiviral.2009.09.014%26rft_id%253Dinfo%253Apmid%252F19887088%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.antiviral.2009.09.014&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=19887088&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2019%2F04%2F12%2F606715.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000274978200005&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference  in text" id="ref-12">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.12" data-doi="10.1016/j.chom.2015.09.009"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Combe</span>,  <span class="cit-name-given-names">M.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Garijo</span>,  <span class="cit-name-given-names">R.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Geller</span>,  <span class="cit-name-given-names">R.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Cuevas</span>,  <span class="cit-name-given-names">J. M.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Sanjuán</span>,  <span class="cit-name-given-names">R.</span></span> (<span class="cit-pub-date">2015</span>).<span class="cit-article-title">Single-cell analysis of RNA virus infection identifies multiple genetically diverse viral genomes within single infectious units</span>. <abbr class="cit-jnl-abbrev">Cell Host Microbe</abbr> <span class="cit-vol">18</span>, <span class="cit-fpage">424</span>–<span class="cit-lpage">432</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCell%2BHost%2BMicrobe%26rft.volume%253D18%26rft.spage%253D424%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.chom.2015.09.009%26rft_id%253Dinfo%253Apmid%252F26468746%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.chom.2015.09.009&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=26468746&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2019%2F04%2F12%2F606715.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference  in text" id="ref-13">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.13"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">de Leuw</span>,  <span class="cit-name-given-names">P.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Stephan</span>,  <span class="cit-name-given-names">C.</span></span> (<span class="cit-pub-date">2018</span>). <span class="cit-article-title">Protease inhibitor therapy for hepatitis C virus-infection</span>. <abbr class="cit-jnl-abbrev">Expert Opin. Pharmacother</abbr>. <span class="cit-vol">19</span>, <span class="cit-fpage">577</span>–<span class="cit-lpage">587</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DExpert%2BOpin.%2BPharmacother%26rft.volume%253D19%26rft.spage%253D577%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference  in text" id="ref-14">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.14" data-doi="10.3201/eid1404.070439"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">De Palma</span>,  <span class="cit-name-given-names">A. M.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Pürstinger</span>,  <span class="cit-name-given-names">G.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Wimmer</span>,  <span class="cit-name-given-names">E.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Patick</span>,  <span class="cit-name-given-names">A. K.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Andries</span>,  <span class="cit-name-given-names">K.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Rombaut</span>,  <span class="cit-name-given-names">B.</span></span>, <span class="cit-auth"><span class="cit-name-surname">De Clercq</span>,  <span class="cit-name-given-names">E.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Neyts</span>,  <span class="cit-name-given-names">J.</span></span> (<span class="cit-pub-date">2008</span>). <span class="cit-article-title">Potential use of antiviral agents in polio eradication</span>. <abbr class="cit-jnl-abbrev">Emerg. Infect. Dis</abbr>. <span class="cit-vol">14</span>, <span class="cit-fpage">545</span>–<span class="cit-lpage">551</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DEmerging%2Binfectious%2Bdiseases%26rft.stitle%253DEmerg%2BInfect%2BDis%26rft.aulast%253DDe%2BPalma%26rft.auinit1%253DA.%2BM.%26rft.volume%253D14%26rft.issue%253D4%26rft.spage%253D545%26rft.epage%253D551%26rft.atitle%253DPotential%2Buse%2Bof%2Bantiviral%2Bagents%2Bin%2Bpolio%2Beradication.%26rft_id%253Dinfo%253Adoi%252F10.3201%252Feid1404.070439%26rft_id%253Dinfo%253Apmid%252F18394270%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.3201/eid1404.070439&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=18394270&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2019%2F04%2F12%2F606715.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000254595000002&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference  in text" id="ref-15">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.15"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Derrida</span>,  <span class="cit-name-given-names">B.</span></span> (<span class="cit-pub-date">1997</span>). <span class="cit-article-title">From random walks to spin glasses</span>. <abbr class="cit-jnl-abbrev">Physica D</abbr> <span class="cit-vol">107</span>, <span class="cit-fpage">186</span>–<span class="cit-lpage">198</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DPhysica%2BD%26rft.volume%253D107%26rft.spage%253D186%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference  in text" id="ref-16">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.16" data-doi="10.1016/S1473-3099(14)70821-7"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Dunning</span>,  <span class="cit-name-given-names">J.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Baillie</span>,  <span class="cit-name-given-names">J. K.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Cao</span>,  <span class="cit-name-given-names">B.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Hayden</span>,  <span class="cit-name-given-names">F. G.</span></span> (<span class="cit-pub-date">2014</span>). <span class="cit-article-title">Antiviral combinations for severe influenza</span>. <abbr class="cit-jnl-abbrev">Lancet Infect. Dis</abbr>. <span class="cit-vol">14</span>, <span class="cit-fpage">1259</span>–<span class="cit-lpage">1270</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DLancet%2BInfect.%2BDis%26rft.volume%253D14%26rft.spage%253D1259%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS1473-3099%252814%252970821-7%26rft_id%253Dinfo%253Apmid%252F25213733%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/S1473-3099(14)70821-7&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=25213733&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2019%2F04%2F12%2F606715.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference  in text" id="ref-17">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.17" data-doi="10.3390/v7102868"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Eltahla</span>,  <span class="cit-name-given-names">A. A.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Luciani</span>,  <span class="cit-name-given-names">F.</span></span>, <span class="cit-auth"><span class="cit-name-surname">White</span>,  <span class="cit-name-given-names">P. A.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Lloyd</span>,  <span class="cit-name-given-names">A. R.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Bull</span>,  <span class="cit-name-given-names">R. A.</span></span> (<span class="cit-pub-date">2015</span>). <span class="cit-article-title">Inhibitors of the hepatitis C virus polymerase, mode of action and resistance</span>. <abbr class="cit-jnl-abbrev">Viruses</abbr> <span class="cit-vol">7</span>, <span class="cit-fpage">5206</span>–<span class="cit-lpage">5224</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DViruses%26rft.volume%253D7%26rft.spage%253D5206%26rft_id%253Dinfo%253Adoi%252F10.3390%252Fv7102868%26rft_id%253Dinfo%253Apmid%252F26426038%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.3390/v7102868&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=26426038&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2019%2F04%2F12%2F606715.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference  in text" id="ref-18">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.18" data-doi="10.1016/j.bbamcr.2011.11.007"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Geller</span>,  <span class="cit-name-given-names">R.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Taguwa</span>,  <span class="cit-name-given-names">S.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Frydman</span>,  <span class="cit-name-given-names">J.</span></span> (<span class="cit-pub-date">2012</span>). <span class="cit-article-title">Broad action of Hsp90 as a host chaperone required for viral replication. Biochim</span>. <abbr class="cit-jnl-abbrev">Biophys. Acta</abbr> <span class="cit-vol">1823</span>, <span class="cit-fpage">698</span>–<span class="cit-lpage">706</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DBiochimica%2Bet%2BBiophysica%2BActa.%2BProtein%2BStructure%2Band%2BMolecular%2BEnzymology%26rft.stitle%253DBiochimica%2Bet%2BBiophysica%2BActa.%2BProtein%2BStructure%2Band%2BMolecular%2BEnzymology%26rft.aulast%253DGeller%26rft.auinit1%253DR.%26rft.volume%253D1823%26rft.issue%253D3%26rft.spage%253D698%26rft.epage%253D706%26rft.atitle%253DBroad%2Baction%2Bof%2BHsp90%2Bas%2Ba%2Bhost%2Bchaperone%2Brequired%2Bfor%2Bviral%2Breplication.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.bbamcr.2011.11.007%26rft_id%253Dinfo%253Apmid%252F22154817%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.bbamcr.2011.11.007&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=22154817&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2019%2F04%2F12%2F606715.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference  in text" id="ref-19">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.19" data-doi="10.1101/gad.1505307"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Geller</span>,  <span class="cit-name-given-names">R.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Vignuzzi</span>,  <span class="cit-name-given-names">M.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Andino</span>,  <span class="cit-name-given-names">R.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Frydman</span>,  <span class="cit-name-given-names">J.</span></span> (<span class="cit-pub-date">2007</span>). <span class="cit-article-title">Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance</span>. <abbr class="cit-jnl-abbrev">Genes Dev</abbr>. <span class="cit-vol">21</span>, <span class="cit-fpage">195</span>–<span class="cit-lpage">205</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DGenes%2B%2526%2BDevelopment%26rft.stitle%253DGenes%2BDev.%26rft.aulast%253DGeller%26rft.auinit1%253DR.%26rft.volume%253D21%26rft.issue%253D2%26rft.spage%253D195%26rft.epage%253D205%26rft.atitle%253DEvolutionary%2Bconstraints%2Bon%2Bchaperone-mediated%2Bfolding%2Bprovide%2Ban%2Bantiviral%2Bapproach%2Brefractory%2Bto%2Bdevelopment%2Bof%2Bdrug%2Bresistance%26rft_id%253Dinfo%253Adoi%252F10.1101%252Fgad.1505307%26rft_id%253Dinfo%253Apmid%252F17234885%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6ODoiZ2VuZXNkZXYiO3M6NToicmVzaWQiO3M6ODoiMjEvMi8xOTUiO3M6NDoiYXRvbSI7czozNzoiL2Jpb3J4aXYvZWFybHkvMjAxOS8wNC8xMi82MDY3MTUuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference  in text" id="ref-20">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.20" data-doi="10.1016/j.celrep.2017.10.051"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Guo</span>,  <span class="cit-name-given-names">F.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Li</span>,  <span class="cit-name-given-names">S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Caglar</span>,  <span class="cit-name-given-names">M. U.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Mao</span>,  <span class="cit-name-given-names">Z.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Liu</span>,  <span class="cit-name-given-names">W.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Woodman</span>,  <span class="cit-name-given-names">A.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Arnold</span>,  <span class="cit-name-given-names">J. J.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Wilke</span>,  <span class="cit-name-given-names">C. O.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Huang</span>,  <span class="cit-name-given-names">T. J.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Cameron</span>,  <span class="cit-name-given-names">C. E.</span></span> (<span class="cit-pub-date">2017</span>). <span class="cit-article-title">Single-cell virology: on-chip investigation of viral infection dynamics</span>. <abbr class="cit-jnl-abbrev">Cell Rep</abbr>. <span class="cit-vol">21</span>, <span class="cit-fpage">1692</span>–<span class="cit-lpage">1704</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCell%2BRep%26rft.volume%253D21%26rft.spage%253D1692%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.celrep.2017.10.051%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.celrep.2017.10.051&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference  in text" id="ref-21">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.21" data-doi="10.1038/ncomms9938"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Heldt</span>,  <span class="cit-name-given-names">F. S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kupke</span>,  <span class="cit-name-given-names">S. Y.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Dorl</span>,  <span class="cit-name-given-names">S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Reichl</span>,  <span class="cit-name-given-names">U.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Frensing</span>,  <span class="cit-name-given-names">T.</span></span> (<span class="cit-pub-date">2015</span>).<span class="cit-article-title">Single-cell analysis and stochastic modelling unveil large cell-to-cell variability in influenza A virus infection</span>. <abbr class="cit-jnl-abbrev">Nat. Commun</abbr>. <span class="cit-vol">6</span>, <span class="cit-fpage">8938</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNat.%2BCommun%26rft.volume%253D6%26rft.spage%253D8938%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fncomms9938%26rft_id%253Dinfo%253Apmid%252F26586423%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/ncomms9938&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=26586423&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2019%2F04%2F12%2F606715.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference  in text" id="ref-22">↵</a><div class="cit ref-cit ref-book" id="cit-606715v1.22"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Hofmann</span>,  <span class="cit-name-given-names">W. P.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Soriano</span>,  <span class="cit-name-given-names">V.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Zeuzem</span>,  <span class="cit-name-given-names">S.</span></span> (<span class="cit-pub-date">2009</span>). <span class="cit-chapter-title">Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection</span>. <span class="cit-source">In Antiviral Strategies</span>. (<span class="cit-publ-name">Berlin, Heidelberg: Springer</span>), pp. <span class="cit-fpage">321</span>–<span class="cit-lpage">346</span>.</cite></div><div class="cit-extra"></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference  in text" id="ref-23">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.23" data-doi="10.2174/092986709788802999"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Hwang</span>,  <span class="cit-name-given-names">M.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Moretti</span>,  <span class="cit-name-given-names">L.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Lu</span>,  <span class="cit-name-given-names">B.</span></span> (<span class="cit-pub-date">2009</span>). <span class="cit-article-title">HSP90 inhibitors: multi-targeted antitumor effects and novel combinatorial therapeutic approaches in cancer therapy</span>. <abbr class="cit-jnl-abbrev">Curr. Med. Chem</abbr>. <span class="cit-vol">16</span>, <span class="cit-fpage">3081</span>–<span class="cit-lpage">3092</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCurrent%2Bmedicinal%2Bchemistry%26rft.stitle%253DCurr%2BMed%2BChem%26rft.aulast%253DHwang%26rft.auinit1%253DM.%26rft.volume%253D16%26rft.issue%253D24%26rft.spage%253D3081%26rft.epage%253D3092%26rft.atitle%253DHSP90%2Binhibitors%253A%2Bmulti-targeted%2Bantitumor%2Beffects%2Band%2Bnovel%2Bcombinatorial%2Btherapeutic%2Bapproaches%2Bin%2Bcancer%2Btherapy.%26rft_id%253Dinfo%253Adoi%252F10.2174%252F092986709788802999%26rft_id%253Dinfo%253Apmid%252F19689285%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.2174/092986709788802999&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=19689285&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2019%2F04%2F12%2F606715.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference  in text" id="ref-24">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.24" data-doi="10.1038/nrd4010"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Jordheim</span>,  <span class="cit-name-given-names">L. P.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Durantel</span>,  <span class="cit-name-given-names">D.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Zoulim</span>,  <span class="cit-name-given-names">F.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Dumontet</span>,  <span class="cit-name-given-names">C.</span></span> (<span class="cit-pub-date">2013</span>). <span class="cit-article-title">Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases</span>. <abbr class="cit-jnl-abbrev">Nat. Rev. Drug Discov</abbr>. <span class="cit-vol">12</span>, <span class="cit-fpage">447</span>–<span class="cit-lpage">464</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNat.%2BRev.%2BDrug%2BDiscov%26rft.volume%253D12%26rft.spage%253D447%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnrd4010%26rft_id%253Dinfo%253Apmid%252F23722347%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nrd4010&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=23722347&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2019%2F04%2F12%2F606715.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference  in text" id="ref-25">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.25" data-doi="10.1016/S0140-6736(03)13077-2"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Peiris</span>,  <span class="cit-name-given-names">J. S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Lai</span>,  <span class="cit-name-given-names">S. T.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Poon</span>,  <span class="cit-name-given-names">L. L.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Guan</span>,  <span class="cit-name-given-names">Y.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Yam</span>,  <span class="cit-name-given-names">L. Y.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Lim</span>,  <span class="cit-name-given-names">W.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Nicholls</span>,  <span class="cit-name-given-names">J.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Yee</span>,  <span class="cit-name-given-names">W. K.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Yan</span>,  <span class="cit-name-given-names">W. W.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Cheung</span>,  <span class="cit-name-given-names">M. T.</span></span>, <span class="cit-etal">et al.</span> (<span class="cit-pub-date">2003</span>). <span class="cit-article-title">Coronavirus as a possible cause of severe acute respiratory syndrome</span>. <abbr class="cit-jnl-abbrev">Lancet</abbr> <span class="cit-vol">361</span>, <span class="cit-fpage">1319</span>–<span class="cit-lpage">1325</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DPeiris%26rft.auinit1%253DJ.%2BS.%26rft.volume%253D361%26rft.issue%253D9366%26rft.spage%253D1319%26rft.epage%253D1325%26rft.atitle%253DCoronavirus%2Bas%2Ba%2Bpossible%2Bcause%2Bof%2Bsevere%2Bacute%2Brespiratory%2Bsyndrome.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252803%252913077-2%26rft_id%253Dinfo%253Apmid%252F12711465%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/S0140-6736(03)13077-2&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=12711465&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2019%2F04%2F12%2F606715.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000182346100007&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference  in text" id="ref-26">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.26" data-doi="10.3390/v1031209"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Pokorna</span>,  <span class="cit-name-given-names">J.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Machala</span>,  <span class="cit-name-given-names">L.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Rezacova</span>,  <span class="cit-name-given-names">P.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Konvalinka</span>,  <span class="cit-name-given-names">J.</span></span> (<span class="cit-pub-date">2009</span>). <span class="cit-article-title">Current and novel inhibitors of HIV protease</span>. <abbr class="cit-jnl-abbrev">Viruses</abbr> <span class="cit-vol">1</span>, <span class="cit-fpage">1209</span>–<span class="cit-lpage">1239</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.stitle%253DViruses%26rft.aulast%253DPokorna%26rft.auinit1%253DJ.%26rft.volume%253D1%26rft.issue%253D3%26rft.spage%253D1209%26rft.epage%253D1239%26rft.atitle%253DCurrent%2Band%2BNovel%2BInhibitors%2Bof%2BHIV%2BProtease.%26rft_id%253Dinfo%253Adoi%252F10.3390%252Fv1031209%26rft_id%253Dinfo%253Apmid%252F21994591%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.3390/v1031209&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=21994591&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2019%2F04%2F12%2F606715.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000280413200044&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference  in text" id="ref-27">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.27" data-doi="10.1371/journal.pone.0141786"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Prince</span>,  <span class="cit-name-given-names">T. L.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kijima</span>,  <span class="cit-name-given-names">T.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Tatokoro</span>,  <span class="cit-name-given-names">M.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Lee</span>,  <span class="cit-name-given-names">S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Tsutsumi</span>,  <span class="cit-name-given-names">S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Yim</span>,  <span class="cit-name-given-names">K.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Rivas</span>,  <span class="cit-name-given-names">C.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Alarcon</span>,  <span class="cit-name-given-names">S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Schwartz</span>,  <span class="cit-name-given-names">H.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Khamit-Kush</span>,  <span class="cit-name-given-names">K.</span></span>, <span class="cit-etal">et al.</span> (<span class="cit-pub-date">2015</span>). <span class="cit-article-title">Client proteins and small molecule inhibitors display distinct binding preferences for constitutive and stress-induced HSP90 isoforms and their conformationally restricted mutants</span>. <abbr class="cit-jnl-abbrev">PLoS One</abbr> <span class="cit-vol">10</span>, <span class="cit-fpage">e0141786</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DPLoS%2BOne%26rft.volume%253D10%26rft.spage%253De0141786%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0141786%26rft_id%253Dinfo%253Apmid%252F26517842%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1371/journal.pone.0141786&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=26517842&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2019%2F04%2F12%2F606715.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference  in text" id="ref-28">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.28"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Raj</span>,  <span class="cit-name-given-names">A.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">van Oudenaarden</span>,  <span class="cit-name-given-names">A.</span></span> (<span class="cit-pub-date">2008</span>). <abbr class="cit-jnl-abbrev">Nature, nurture, or chance: stochastic gene expression and its consequences</abbr>. 2008, <span class="cit-vol">135</span>, <span class="cit-fpage">216</span>–<span class="cit-lpage">226</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%252C%2Bnurture%252C%2Bor%2Bchance%253A%2Bstochastic%2Bgene%2Bexpression%2Band%2Bits%2Bconsequences%26rft.volume%253D135%26rft.spage%253D216%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference  in text" id="ref-29">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.29" data-doi="10.1021/jm980403y"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Roe</span>,  <span class="cit-name-given-names">S. M.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Prodromou</span>,  <span class="cit-name-given-names">C.</span></span>, <span class="cit-auth"><span class="cit-name-surname">O’Brien</span>,  <span class="cit-name-given-names">R.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Ladbury</span>,  <span class="cit-name-given-names">J. E.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Piper</span>,  <span class="cit-name-given-names">P. W.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Pearl</span>,  <span class="cit-name-given-names">L. H.</span></span> (<span class="cit-pub-date">1999</span>). <span class="cit-article-title">Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin</span>. <abbr class="cit-jnl-abbrev">J. Med. Chem</abbr>. <span class="cit-vol">42</span>, <span class="cit-fpage">260</span>–<span class="cit-lpage">266</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2Bmedicinal%2Bchemistry%26rft.stitle%253DJ%2BMed%2BChem%26rft.aulast%253DRoe%26rft.auinit1%253DS.%2BM.%26rft.volume%253D42%26rft.issue%253D2%26rft.spage%253D260%26rft.epage%253D266%26rft.atitle%253DStructural%2Bbasis%2Bfor%2Binhibition%2Bof%2Bthe%2BHsp90%2Bmolecular%2Bchaperone%2Bby%2Bthe%2Bantitumor%2Bantibiotics%2Bradicicol%2Band%2Bgeldanamycin.%26rft_id%253Dinfo%253Adoi%252F10.1021%252Fjm980403y%26rft_id%253Dinfo%253Apmid%252F9925731%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1021/jm980403y&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=9925731&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2019%2F04%2F12%2F606715.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000078361300010&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-30-1" title="View reference  in text" id="ref-30">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.30" data-doi="10.7554/eLife.32303"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Russell</span>,  <span class="cit-name-given-names">A. B.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Trapnell</span>,  <span class="cit-name-given-names">C.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Bloom</span>,  <span class="cit-name-given-names">J. D.</span></span> (<span class="cit-pub-date">2018</span>). <span class="cit-article-title">Extreme heterogeneity of influenza virus infection in single cells</span>. <abbr class="cit-jnl-abbrev">Elife</abbr> <span class="cit-vol">7</span>, <span class="cit-fpage">e32303</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DElife%26rft.volume%253D7%26rft.spage%253De32303%26rft_id%253Dinfo%253Adoi%252F10.7554%252FeLife.32303%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.7554/eLife.32303&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-31-1" title="View reference  in text" id="ref-31">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.31"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Sidera</span>,  <span class="cit-name-given-names">K.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Patsavoudi</span>,  <span class="cit-name-given-names">E.</span></span> (<span class="cit-pub-date">2014</span>). <span class="cit-article-title">HSP90 inhibitors: current development and potential in cancer therapy. Recent Pat</span>. <abbr class="cit-jnl-abbrev">Anticancer Drug Discov</abbr>. <span class="cit-vol">9</span>, <span class="cit-fpage">1</span>–<span class="cit-lpage">20</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAnticancer%2BDrug%2BDiscov%26rft.volume%253D9%26rft.spage%253D1%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-32-1" title="View reference  in text" id="ref-32">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.32" data-doi="10.1021/jm201384j"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Sofia</span>,  <span class="cit-name-given-names">M. J.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Chang</span>,  <span class="cit-name-given-names">W. S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Furman</span>,  <span class="cit-name-given-names">P. A.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Mosley</span>,  <span class="cit-name-given-names">R. T.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Ross</span>,  <span class="cit-name-given-names">B. S.</span></span> (<span class="cit-pub-date">2012</span>). <span class="cit-article-title">Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA- polymerase</span>. <abbr class="cit-jnl-abbrev">J. Med. Chem</abbr>. <span class="cit-vol">55</span>, <span class="cit-fpage">2481</span>–<span class="cit-lpage">2531</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2Bmedicinal%2Bchemistry%26rft.stitle%253DJ%2BMed%2BChem%26rft.aulast%253DSofia%26rft.auinit1%253DM.%2BJ.%26rft.volume%253D55%26rft.issue%253D6%26rft.spage%253D2481%26rft.epage%253D2531%26rft.atitle%253DNucleoside%252C%2Bnucleotide%252C%2Band%2Bnon-nucleoside%2Binhibitors%2Bof%2Bhepatitis%2BC%2Bvirus%2BNS5B%2BRNA-dependent%2BRNA-polymerase.%26rft_id%253Dinfo%253Adoi%252F10.1021%252Fjm201384j%26rft_id%253Dinfo%253Apmid%252F22185586%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1021/jm201384j&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=22185586&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2019%2F04%2F12%2F606715.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-33-1" title="View reference  in text" id="ref-33">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.33"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Stuyver</span>,  <span class="cit-name-given-names">L. J.</span></span>, <span class="cit-auth"><span class="cit-name-surname">McBrayer</span>,  <span class="cit-name-given-names">T. R.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Tharnish</span>,  <span class="cit-name-given-names">P. M.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Clark</span>,  <span class="cit-name-given-names">J.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Hollecker</span>,  <span class="cit-name-given-names">L.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Lostia</span>,  <span class="cit-name-given-names">S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Nachman</span>,  <span class="cit-name-given-names">T.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Grier</span>,  <span class="cit-name-given-names">J.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Bennett</span>,  <span class="cit-name-given-names">M. A.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Xie</span>,  <span class="cit-name-given-names">M. Y.</span></span>, <span class="cit-etal">et al.</span> (<span class="cit-pub-date">2006</span>). <span class="cit-article-title">Inhibition of hepatitis C replicon RNA synthesis by beta-D-2’-deoxy-2’-fluoro-2’-C-methylcytidine: a specific inhibitor of hepatitis C virus replication. Antivir</span>. <abbr class="cit-jnl-abbrev">Chem. Chemother</abbr>. <span class="cit-vol">17</span>, <span class="cit-fpage">79</span>–<span class="cit-lpage">87</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DChem.%2BChemother%26rft.volume%253D17%26rft.spage%253D79%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-34-1" title="View reference  in text" id="ref-34">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.34"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Wang</span>,  <span class="cit-name-given-names">H. M.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Liang</span>,  <span class="cit-name-given-names">P. H.</span></span> (<span class="cit-pub-date">2010</span>). <span class="cit-article-title">Picornaviral 3C protease inhibitors and the dual 3C protease/coronaviral 3C-like protease inhibitors</span>. <abbr class="cit-jnl-abbrev">Expert Opin. Ther. Pat</abbr>. <span class="cit-vol">20</span>, <span class="cit-fpage">59</span>–<span class="cit-lpage">71</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.stitle%253DExpert%2BOpin%2BTher%2BPat%26rft.aulast%253DWang%26rft.auinit1%253DH.%2BM.%26rft.volume%253D20%26rft.issue%253D1%26rft.spage%253D59%26rft.epage%253D71%26rft.atitle%253DPicornaviral%2B3C%2Bprotease%2Binhibitors%2Band%2Bthe%2Bdual%2B3C%2Bprotease%252Fcoronaviral%2B3C-like%2Bprotease%2Binhibitors.%26rft_id%253Dinfo%253Apmid%252F20021285%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=20021285&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2019%2F04%2F12%2F606715.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-35-1" title="View reference  in text" id="ref-35">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.35" data-doi="10.1007/s00705-017-3511-1"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Wang</span>,  <span class="cit-name-given-names">Y.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Jin</span>,  <span class="cit-name-given-names">F.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Wang</span>,  <span class="cit-name-given-names">R.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Li</span>,  <span class="cit-name-given-names">F.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Wu</span>,  <span class="cit-name-given-names">Y.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Kitazato</span>,  <span class="cit-name-given-names">K.</span></span> (<span class="cit-pub-date">2017</span>). <span class="cit-article-title">HSP90: a promising broad-spectrum antiviral drug target</span>. <abbr class="cit-jnl-abbrev">Arch. Virol</abbr>. <span class="cit-vol">162</span>, <span class="cit-fpage">3269</span>–<span class="cit-lpage">3282</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DArch.%2BVirol%26rft.volume%253D162%26rft.spage%253D3269%26rft_id%253Dinfo%253Adoi%252F10.1007%252Fs00705-017-3511-1%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1007/s00705-017-3511-1&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-36-1" title="View reference  in text" id="ref-36">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.36" data-doi="10.1103/PhysRevLett.81.22"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Wiseman</span>,  <span class="cit-name-given-names">S.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Domany</span>,  <span class="cit-name-given-names">E.</span></span> (<span class="cit-pub-date">1998</span>). <span class="cit-article-title">Finite-size scaling and lack of self-averaging in critical disordered systems</span>. <abbr class="cit-jnl-abbrev">Phys. Rev. Lett</abbr>. <span class="cit-vol">81</span>, <span class="cit-fpage">22</span>–<span class="cit-lpage">25</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DPhys.%2BRev.%2BLett%26rft.volume%253D81%26rft.spage%253D22%26rft_id%253Dinfo%253Adoi%252F10.1103%252FPhysRevLett.81.22%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1103/PhysRevLett.81.22&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-37-1" title="View reference  in text" id="ref-37">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.37" data-doi="10.1146/annurev.biophys.27.1.249"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Wlodawer</span>,  <span class="cit-name-given-names">A.</span></span>, and <span class="cit-auth"><span class="cit-name-surname">Vondrasek</span>,  <span class="cit-name-given-names">J.</span></span> (<span class="cit-pub-date">1998</span>). <span class="cit-article-title">Inhibitors of HIV-1 protease: A major success of structure-assisted drug design</span>. <abbr class="cit-jnl-abbrev">Annu. Rev. Biophys. Biomol. Struct</abbr>. <span class="cit-vol">27</span>, <span class="cit-fpage">249</span>–<span class="cit-lpage">284</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAnnual%2Breview%2Bof%2Bbiophysics%2Band%2Bbiomolecular%2Bstructure%26rft.stitle%253DAnnu%2BRev%2BBiophys%2BBiomol%2BStruct%26rft.aulast%253DWlodawer%26rft.auinit1%253DA.%26rft.volume%253D27%26rft.issue%253D1%26rft.spage%253D249%26rft.epage%253D284%26rft.atitle%253DINHIBITORS%2BOF%2BHIV-1%2BPROTEASE%253A%2BA%2BMajor%2BSuccess%2Bof%2BStructure-Assisted%2BDrug%2BDesign%26rft_id%253Dinfo%253Adoi%252F10.1146%252Fannurev.biophys.27.1.249%26rft_id%253Dinfo%253Apmid%252F9646869%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1146/annurev.biophys.27.1.249&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=9646869&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2019%2F04%2F12%2F606715.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000074324000011&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label ref-label-empty"></span><a class="rev-xref-ref" href="#xref-ref-38-1" title="View reference  in text" id="ref-38">↵</a><div class="cit ref-cit ref-journal" id="cit-606715v1.38" data-doi="10.1158/1535-7163.MCT-11-0755"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Ying</span>,  <span class="cit-name-given-names">W.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Du</span>,  <span class="cit-name-given-names">Z.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Sun</span>,  <span class="cit-name-given-names">L.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Foley</span>,  <span class="cit-name-given-names">K. P.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Proia</span>,  <span class="cit-name-given-names">D. A.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Blackman</span>,  <span class="cit-name-given-names">R. K.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Zhou</span>,  <span class="cit-name-given-names">D.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Inoue</span>,  <span class="cit-name-given-names">T.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Tatsuta</span>,  <span class="cit-name-given-names">N.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Sang</span>,  <span class="cit-name-given-names">J.</span></span>, <span class="cit-etal">et al.</span> (<span class="cit-pub-date">2012</span>). <span class="cit-article-title">Ganetespib, a unique triazolone-containing Hsp90 inhibitor, exhibits potent antitumor activity and a superior safety profile for cancer therapy</span>. <abbr class="cit-jnl-abbrev">Mol. Cancer Ther</abbr>. <span class="cit-vol">11</span>, <span class="cit-fpage">475</span>–<span class="cit-lpage">484</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DMol.%2BCancer%2BTher%26rft_id%253Dinfo%253Adoi%252F10.1158%252F1535-7163.MCT-11-0755%26rft_id%253Dinfo%253Apmid%252F22144665%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MTA6Im1vbGNhbnRoZXIiO3M6NToicmVzaWQiO3M6ODoiMTEvMi80NzUiO3M6NDoiYXRvbSI7czozNzoiL2Jpb3J4aXYvZWFybHkvMjAxOS8wNC8xMi82MDY3MTUuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li></ol></div><span class="highwire-journal-article-marker-end"></span></div><span id="related-urls"></span></div><a href="https://www.biorxiv.org/content/10.1101/606715v1.abstract" class="hw-link hw-link-article-abstract" data-icon-position="" data-hide-link-title="0">View Abstract</a></div>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-disqus-comment" >
  
      
  
  <div class="pane-content">
    <div id="disqus_thread"><noscript><p><a href="http://biorxivstage.disqus.com/?url=https%3A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.1101%2F606715v1" class="" data-icon-position="" data-hide-link-title="0">View the discussion thread.</a></p></noscript></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-back-to-top" >
  
      
  
  <div class="pane-content">
    <a href="#page" class="back-to-top" data-icon-position="" data-hide-link-title="0"><i class="icon-chevron-up"></i> Back to top</a>  </div>

  
  </div>
</div>
			</div>
		</div>
		
		<div class="sidebar-right-wrapper grid-10 omega">
			<div class="panel-panel panel-region-sidebar-right">
			  <div class="inside"><div class="panel-pane pane-highwire-node-pager" >
  
      
  
  <div class="pane-content">
    <div class="pager highwire-pager pager-mini clearfix highwire-node-pager highwire-article-pager"><span class="pager-prev"><a href="/content/10.1101/606889v1" title="Spatiotemporal organization of branched microtubule networks" rel="prev" class="pager-link-prev link-icon"><i class="icon-circle-arrow-left"></i> <span class="title">Previous</span></a></span><span class="pager-next"><a href="/content/10.1101/283929v2-0" title="Cell-type heterogeneity in adipose tissue is associated with complex traits and reveals disease-relevant cell-specific eQTLs" rel="next" class="pager-link-next link-icon-right link-icon"><span class="title">Next</span> <i class="icon-circle-arrow-right"></i></a></span></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-1" >
  
      
  
  <div class="pane-content">
    Posted&nbsp;April 12, 2019.  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-art-tools" >
  
      
  
  <div class="pane-content">
    <div id="mini-panel-biorxiv_art_tools" class="highwire-2col-stacked panel-display">
	  
  <div class="panel-row-wrapper clearfix">
		<div class="content-left-wrapper content-column">
          <div class="panel-panel panel-region-content-left">
            <div class="inside"><div class="panel-pane pane-highwire-variant-link" >
  
      
  
  <div class="pane-content">
    <a href="/content/10.1101/606715v1.full.pdf" target="_self" class="article-dl-pdf-link link-icon"><i class="icon-external-link-sign"></i> <span class="title">Download PDF</span></a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-biorxiv-supplementary-fragment" >
  
      
  
  <div class="pane-content">
    <p><a href="/content/10.1101/606715v1.supplementary-material"><i class="icon-file"></i>Supplementary Material </a></p>  </div>

  
  </div>
</div>
          </div>
        </div>
        
        <div class="content-right-wrapper content-column">
          <div class="panel-panel panel-region-content-right">
            <div class="inside"><div class="panel-pane pane-minipanel-dialog-link pane-biorxiv-art-email" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger" title="Email this Article" data-icon-position="" data-hide-link-title="0"><i class = 'icon-envelope'></i> Email</a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_art_email">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-block pane-forward-form pane-forward" >
  
      
  
  <div class="pane-content">
    <form action="/content/10.1101/606715v1.full" method="post" id="forward-form" accept-charset="UTF-8"><div><div id="edit-instructions" class="form-item form-item-label-before form-type-item">
 <p>Thank you for your interest in spreading the word about bioRxiv.</p><p>NOTE: Your email address is requested solely to identify you as the sender of this article.</p>
</div>
<div class="form-item form-item-label-before form-type-textfield form-item-email">
  <label for="edit-email">Your Email <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-email" name="email" value="" size="58" maxlength="256" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-textfield form-item-name">
  <label for="edit-name">Your Name <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-name" name="name" value="" size="58" maxlength="256" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-textarea form-item-recipients">
  <label for="edit-recipients">Send To <span class="form-required" title="This field is required.">*</span></label>
 <div class="form-textarea-wrapper resizable"><textarea id="edit-recipients" name="recipients" cols="50" rows="5" class="form-textarea required"></textarea></div>
<div class="description">Enter multiple addresses on separate lines or separate them with commas.</div>
</div>
<div id="edit-page" class="form-item form-item-label-before form-type-item">
  <label for="edit-page">You are going to email the following </label>
 <a href="/content/10.1101/606715v1" class="active" data-icon-position="" data-hide-link-title="0">More than efficacy revealed by single-cell analysis of antiviral therapeutics</a>
</div>
<div id="edit-subject" class="form-item form-item-label-before form-type-item">
  <label for="edit-subject">Message Subject </label>
 (Your Name) has forwarded a page to you from bioRxiv
</div>
<div id="edit-body" class="form-item form-item-label-before form-type-item">
  <label for="edit-body">Message Body </label>
 (Your Name) thought you would like to see this page from the bioRxiv website.
</div>
<div class="form-item form-item-label-before form-type-textarea form-item-message">
  <label for="edit-message--2">Your Personal Message </label>
 <div class="form-textarea-wrapper resizable"><textarea id="edit-message--2" name="message" cols="50" rows="10" class="form-textarea"></textarea></div>
</div>
<input type="hidden" name="path" value="node/596459" />
<input type="hidden" name="path_cid" value="" />
<input type="hidden" name="forward_footer" value=" " />
<input type="hidden" name="form_build_id" value="form-vhc_FyZj860OVsmsj_K7SdSpGf3iCDeT3fQiiqFQ4D0" />
<input type="hidden" name="form_id" value="forward_form" />
<div class="form-actions form-wrapper" id="edit-actions"><input type="submit" id="edit-submit" name="op" value="Send Message" class="form-submit" /></div></div></form>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-share-link highwire_clipboard_link_ajax"  id="shareit">
  
      
  
  <div class="pane-content">
    <a href="/" class="link-icon"><i class="icon-share-alt"></i> <span class="title">Share</span></a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-share highwire_clipboard_form_ajax_shareit" >
  
      
  
  <div class="pane-content">
    
<div class="panel-display omega-12-onecol" id="mini-panel-biorxiv_share">

		  <div class="panel-panel grid-12 panel-region-preface">
		  <div class="inside"><div class="panel-pane pane-highwire-article-citation" >
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="596459" id="node596459--2" data-pisa="biorxiv;606715v1" data-pisa-master="biorxiv;606715" data-seqnum="596459" data-apath="/biorxiv/early/2019/04/12/606715.atom"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix" >

      <div class="highwire-cite-title" >
      <div class="highwire-cite-title">More than efficacy revealed by single-cell analysis of antiviral therapeutics</div>    </div>
  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Wu</span> <span class="nlm-surname">Liu</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Mehmet U.</span> <span class="nlm-surname">Caglar</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Zhangming</span> <span class="nlm-surname">Mao</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Andrew</span> <span class="nlm-surname">Woodman</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Jamie J.</span> <span class="nlm-surname">Arnold</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">Claus O.</span> <span class="nlm-surname">Wilke</span></span>, <span class="highwire-citation-author" data-delta="6"><span class="nlm-given-names">Craig E.</span> <span class="nlm-surname">Cameron</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-journal highwire-cite-metadata">bioRxiv </span><span  class="highwire-cite-metadata-pages highwire-cite-metadata">606715; </span><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="doi_label">doi:</span> https://doi.org/10.1101/606715 </span></div>
  
  
  </div>
</div>  </div>

  
  </div>
</div>
	  </div>
	
  <div class="panel-panel grid-12 panel-region-content">
  	<div class="inside"><div class="panel-pane pane-highwire-article-clipboard-copy" >
  
      
  
  <div class="pane-content">
    <div class = "clipboard-copy">
  <span class="label-url">
    <label for="dynamic">Share This Article:</label>
  </span>
  <span class="input-text-url">
    <input type="text" id="dynamic" value="https://www.biorxiv.org/content/10.1101/606715v1" size="50"/>
  </span>
  <span class="copy-button button">
    <button id="copy-dynamic" class="clipboardjs-button" data-clipboard-target="#dynamic" data-clipboard-alert-style="tooltip" data-clipboard-alert-text="Copied!">Copy</button>
  </span>
</div>
  </div>

  
  </div>
</div>
  </div>
	
		  <div class="panel-panel grid-12 panel-region-postscript">
	    <div class="inside"><div class="panel-pane pane-service-links" >
  
      
  
  <div class="pane-content">
    <div class="service-links"><a href="http://digg.com/submit?phase=2&amp;url=https%3A//www.biorxiv.org/content/10.1101/606715v1&amp;title=More%20than%20efficacy%20revealed%20by%20single-cell%20analysis%20of%20antiviral%20therapeutics" id="digg" title="Digg this post on digg.com" class="service-links-digg" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/digg.png" alt="Digg logo" /></a> <a href="http://reddit.com/submit?url=https%3A//www.biorxiv.org/content/10.1101/606715v1&amp;title=More%20than%20efficacy%20revealed%20by%20single-cell%20analysis%20of%20antiviral%20therapeutics" id="reddit" title="Submit this post on reddit.com" class="service-links-reddit" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/reddit.png" alt="Reddit logo" /></a> <a href="http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.1101/606715v1&amp;text=More%20than%20efficacy%20revealed%20by%20single-cell%20analysis%20of%20antiviral%20therapeutics" id="twitter" title="Share this on Twitter" class="service-links-twitter" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png" alt="Twitter logo" /></a> <a href="http://www.citeulike.org/posturl?url=https%3A//www.biorxiv.org/content/10.1101/606715v1&amp;title=More%20than%20efficacy%20revealed%20by%20single-cell%20analysis%20of%20antiviral%20therapeutics" id="citeulike" title="Share on CiteULike" class="service-links-citeulike" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/citeyoulike.png" alt="CiteULike logo" /></a> <a href="http://www.facebook.com/sharer.php?u=https%3A//www.biorxiv.org/content/10.1101/606715v1&amp;t=More%20than%20efficacy%20revealed%20by%20single-cell%20analysis%20of%20antiviral%20therapeutics" id="facebook" title="Share on Facebook" class="service-links-facebook" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png" alt="Facebook logo" /></a> <a href="http://www.google.com/bookmarks/mark?op=add&amp;bkmk=https%3A//www.biorxiv.org/content/10.1101/606715v1&amp;title=More%20than%20efficacy%20revealed%20by%20single-cell%20analysis%20of%20antiviral%20therapeutics" id="google" title="Bookmark this post on Google" class="service-links-google" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/google-32.png" alt="Google logo" /></a> <a href="http://www.mendeley.com/import/?url=https%3A//www.biorxiv.org/content/10.1101/606715v1&amp;title=More%20than%20efficacy%20revealed%20by%20single-cell%20analysis%20of%20antiviral%20therapeutics" id="mendeley" title="Share on Mendeley" class="service-links-mendeley" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png" alt="Mendeley logo" /></a></div>  </div>

  
  </div>
</div>
	  </div>
	
</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-minipanel-dialog-link pane-biorxiv-cite-tool" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger link-icon" title="Citation Tools"><i class="icon-globe"></i> <span class="title">Citation Tools</span></a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_cite_tool">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-citation-export" >
  
      
  
  <div class="pane-content">
    <div class="highwire-citation-export">  
  <div class="highwire-citation-info">
      <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="596459" id="node596459--3" data-pisa="biorxiv;606715v1" data-pisa-master="biorxiv;606715" data-seqnum="596459" data-apath="/biorxiv/early/2019/04/12/606715.atom"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix" >

      <div class="highwire-cite-title" >
      <div class="highwire-cite-title">More than efficacy revealed by single-cell analysis of antiviral therapeutics</div>    </div>
  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Wu</span> <span class="nlm-surname">Liu</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Mehmet U.</span> <span class="nlm-surname">Caglar</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Zhangming</span> <span class="nlm-surname">Mao</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Andrew</span> <span class="nlm-surname">Woodman</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Jamie J.</span> <span class="nlm-surname">Arnold</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">Claus O.</span> <span class="nlm-surname">Wilke</span></span>, <span class="highwire-citation-author" data-delta="6"><span class="nlm-given-names">Craig E.</span> <span class="nlm-surname">Cameron</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-journal highwire-cite-metadata">bioRxiv </span><span  class="highwire-cite-metadata-pages highwire-cite-metadata">606715; </span><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="doi_label">doi:</span> https://doi.org/10.1101/606715 </span></div>
  
  
  </div>
</div>  </div>
  <div class="highwire-citation-formats">
  	      <h2>Citation Manager Formats</h2>
        <div class="highwire-citation-formats-links">
      <span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.spage&amp;rft.epage&amp;rft.atitle=More%20than%20efficacy%20revealed%20by%20single-cell%20analysis%20of%20antiviral%20therapeutics&amp;rft.volume&amp;rft.issue&amp;rft.date=2019-01-01%2000%3A00%3A00&amp;rft.stitle&amp;rft.jtitle=bioRxiv&amp;rft.au=Liu%2C+Wu&amp;rft.au=Caglar%2C+Mehmet+U.&amp;rft.au=Mao%2C+Zhangming&amp;rft.au=Woodman%2C+Andrew&amp;rft.au=Arnold%2C+Jamie+J.&amp;rft.au=Wilke%2C+Claus+O.&amp;rft.au=Cameron%2C+Craig+E."></span><ul class="hw-citation-links inline button button-alt button-grid clearfix"><li class="bibtext first"><a href="/highwire/citation/596459/bibtext" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">BibTeX</a></li><li class="bookends"><a href="/highwire/citation/596459/bookends" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Bookends</a></li><li class="easybib"><a href="/highwire/citation/596459/easybib" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EasyBib</a></li><li class="endnote-tagged"><a href="/highwire/citation/596459/endnote-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EndNote (tagged)</a></li><li class="endnote-8-xml"><a href="/highwire/citation/596459/endnote-8-xml" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EndNote 8 (xml)</a></li><li class="medlars"><a href="/highwire/citation/596459/medlars" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Medlars</a></li><li class="mendeley"><a href="/highwire/citation/596459/mendeley" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Mendeley</a></li><li class="papers"><a href="/highwire/citation/596459/papers" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Papers</a></li><li class="refworks-tagged"><a href="/highwire/citation/596459/refworks-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">RefWorks Tagged</a></li><li class="reference-manager"><a href="/highwire/citation/596459/reference-manager" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Ref Manager</a></li><li class="ris"><a href="/highwire/citation/596459/ris" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">RIS</a></li><li class="zotero last"><a href="/highwire/citation/596459/zotero" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Zotero</a></li></ul>    </div>
  </div>
</div>
  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
</div>
          </div>
        </div>
	</div> <!-- /.panel-row-wrapper -->	
	
	</div>

  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-service-links" >
  
      
  
  <div class="pane-content">
    <div class="service-links"><div class="item-list"><ul><li class="first"><a href="http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.1101/606715v1&amp;count=horizontal&amp;via=&amp;text=More%20than%20efficacy%20revealed%20by%20single-cell%20analysis%20of%20antiviral%20therapeutics&amp;counturl=https%3A//www.biorxiv.org/content/10.1101/606715v1" class="twitter-share-button service-links-twitter-widget" id="twitter_widget" title="Tweet This" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Tweet Widget</span></a></li><li><a href="http://www.facebook.com/plugins/like.php?href=https%3A//www.biorxiv.org/content/10.1101/606715v1&amp;layout=button_count&amp;show_faces=false&amp;action=like&amp;colorscheme=light&amp;width=100&amp;height=21&amp;font=&amp;locale=" id="facebook_like" title="I Like it" class="service-links-facebook-like" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Facebook Like</span></a></li><li class="last"><a href="https://www.biorxiv.org/content/10.1101/606715v1" id="google_plus_one" title="Plus it" class="service-links-google-plus-one" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Google Plus One</span></a></li></ul></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-article-collections" >
  
        <h2 class="pane-title">Subject Area</h2>
    
  
  <div class="pane-content">
    <div class="highwire-list-wrapper highwire-article-collections"><div class="highwire-list"><ul class="highwire-article-collection-term-list"><li class="first last odd"><span class="highwire-article-collection-term"><a href="/collection/microbiology" class="highlight" data-icon-position="" data-hide-link-title="0">Microbiology<i class="icon-caret-right"></i>
</a></span></li></ul></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-subject-collections block-style-col2" >
  
      
  
  <div class="pane-content">
    <div class="panel-flexible panels-flexible-8 clearfix" id="mini-panel-biorxiv_subject_collections">
<div class="panel-flexible-inside panels-flexible-8-inside">
<div class="panels-flexible-region panels-flexible-region-8-center panels-flexible-region-first panels-flexible-region-last">
  <div class="inside panels-flexible-region-inside panels-flexible-region-8-center-inside panels-flexible-region-inside-first panels-flexible-region-inside-last">
<div class="panel-pane pane-snippet" >
  
      
  
  <div class="pane-content">
    <div class="snippet biorxiv-subject-areas-table-title" id="biorxiv-subject-areas-table-title">
  
      
  <div class="snippet-content">
    <b>Subject Areas</b>  </div>

</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-snippet" >
  
      
  
  <div class="pane-content">
    <div class="snippet biorxiv-subject-areas-view-papers" id="biorxiv-subject-areas-view-papers">
  
      
  <div class="snippet-content">
    <a href="/content/early/recent"><strong>All Articles</strong></a>  </div>

</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-subject-collections" >
  
      
  
  <div class="pane-content">
    <ul id="collection" class="collection highwire-list-expand"><li class="outer collection depth-2  child first"><div class = "data-wrapper"><a href="/collection/animal-behavior-and-cognition" class="" data-icon-position="" data-hide-link-title="0">Animal Behavior and Cognition</a> <span class = "article-count">(1789)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/biochemistry" class="" data-icon-position="" data-hide-link-title="0">Biochemistry</a> <span class = "article-count">(3141)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/bioengineering" class="" data-icon-position="" data-hide-link-title="0">Bioengineering</a> <span class = "article-count">(2136)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/bioinformatics" class="" data-icon-position="" data-hide-link-title="0">Bioinformatics</a> <span class = "article-count">(11098)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/biophysics" class="" data-icon-position="" data-hide-link-title="0">Biophysics</a> <span class = "article-count">(4575)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/cancer-biology" class="" data-icon-position="" data-hide-link-title="0">Cancer Biology</a> <span class = "article-count">(3584)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/cell-biology" class="" data-icon-position="" data-hide-link-title="0">Cell Biology</a> <span class = "article-count">(5072)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/clinical-trials" class="" data-icon-position="" data-hide-link-title="0">Clinical Trials</a> <span class = "article-count">(137)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/developmental-biology" class="" data-icon-position="" data-hide-link-title="0">Developmental Biology</a> <span class = "article-count">(3114)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/ecology" class="" data-icon-position="" data-hide-link-title="0">Ecology</a> <span class = "article-count">(4915)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/epidemiology" class="" data-icon-position="" data-hide-link-title="0">Epidemiology</a> <span class = "article-count">(2044)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/evolutionary-biology" class="" data-icon-position="" data-hide-link-title="0">Evolutionary Biology</a> <span class = "article-count">(7708)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/genetics" class="" data-icon-position="" data-hide-link-title="0">Genetics</a> <span class = "article-count">(5844)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/genomics" class="" data-icon-position="" data-hide-link-title="0">Genomics</a> <span class = "article-count">(7321)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/immunology" class="" data-icon-position="" data-hide-link-title="0">Immunology</a> <span class = "article-count">(2735)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/microbiology" class="" data-icon-position="" data-hide-link-title="0">Microbiology</a> <span class = "article-count">(8398)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/molecular-biology" class="" data-icon-position="" data-hide-link-title="0">Molecular Biology</a> <span class = "article-count">(3345)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/neuroscience" class="" data-icon-position="" data-hide-link-title="0">Neuroscience</a> <span class = "article-count">(20276)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/paleontology" class="" data-icon-position="" data-hide-link-title="0">Paleontology</a> <span class = "article-count">(147)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/pathology" class="" data-icon-position="" data-hide-link-title="0">Pathology</a> <span class = "article-count">(529)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/pharmacology-and-toxicology" class="" data-icon-position="" data-hide-link-title="0">Pharmacology and Toxicology</a> <span class = "article-count">(867)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/physiology" class="" data-icon-position="" data-hide-link-title="0">Physiology</a> <span class = "article-count">(1311)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/plant-biology" class="" data-icon-position="" data-hide-link-title="0">Plant Biology</a> <span class = "article-count">(3026)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/scientific-communication-and-education" class="" data-icon-position="" data-hide-link-title="0">Scientific Communication and Education</a> <span class = "article-count">(736)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/synthetic-biology" class="" data-icon-position="" data-hide-link-title="0">Synthetic Biology</a> <span class = "article-count">(976)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/systems-biology" class="" data-icon-position="" data-hide-link-title="0">Systems Biology</a> <span class = "article-count">(3039)</span></div></li>
<li class="outer collection depth-2  child last"><div class = "data-wrapper"><a href="/collection/zoology" class="" data-icon-position="" data-hide-link-title="0">Zoology</a> <span class = "article-count">(503)</span></div></li>
</ul>  </div>

  
  </div>
  </div>
</div>
</div>
</div>
  </div>

  
  </div>
</div>
			</div>
		</div>
	
	</div> <!-- /.panel-row-wrapper -->	
	
	</div>

    </div>
  </div>
</div>      </div>
</div>  </div>
</section>    
  
  </div>    <div class="region region-page-bottom" id="region-page-bottom">
  <div class="region-inner region-page-bottom-inner">
      </div>
</div><script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__VNH5GD8Zz7g6_hGCOZjVjdMndxxC6naiExSSJKX3k_A__kzmEdtbqCsJx5Z9yg2Qy0PptB__ufXm-TxUOl0KZzUw__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__2WRbxlwOW0MEUc_hSWU5MBepQg6Lch6O5SZwefpJ6IE__HCL0YQJqLkOhrLPZZYGqosGvtFsEHMGghHIkSx4y9vA__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js" defer="defer"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__llgGUcz2-k3Jmyyyog-_4yI1wJfGWwx0eQ2lbnM9IIo__t6UjIjIKIAD6nKc6BAU9qmlVV2VR4CBTNQbxlbJPgN0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
function euCookieComplianceLoadScripts() {}
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var eu_cookie_compliance_cookie_name = "";
//--><!]]>
</script>
<script type="text/javascript" src="//d33xdlntwy0kbs.cloudfront.net/cshl_custom.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__BmqjBnkz3MgYCAoc25s1lDRMEjLhC3mEPVonUFIHi08__Unwv5-ZIuHBfFwytsjEx1niBVJ7n1T4lPws7VrkHXM4__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
  </body>
</html>
